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      INTRODUCTION 
 
     ‘nja;tj;jhy; MfhnjdpDk; Kaw;rp jd; 
                       nka;tUj;jf; $yp jUk;”. 
 
Before seeing the evolution of various systems of medicine, let us see a few 
words about the evolution of earth and its mankind. The history of the earth 
describes the most important events and fundamental stages in the development of 
the planet Earth from its formation 4.578 billion years ago to the present day. All 
branches of natural science have contributed to understand the concept of the main 
events of the Earth’s past. For example 
Formation of universe is well explained in Siddha text books like 
“Njhw;wf;fpuk Muha;r;rpAk; rpj;j kUj;Jt tuyhWk;” which quotes that basic 
principle for evolution is 
‘cs;sJ NghfhJ ,y;yJ thuhJ”      and 
‘khw;wj;jhy; MaJ ,t;Tyfk;” 
Biological and Geological changes have been constantly occurring on our 
planet since the time of its formation causing continuous evolution of organisms. In 
the origin of species, Charles Darwin (1859) hypothesized that new species arise by 
the modification of existing one – that the raw material of life is life.  
The primitive man due to civilization starts to move away from nature and 
slowly disease entered the world. So based on the requirement man gradually 
acquired knowledge about the medicine.The term Medicine arose out of the primal 
sympathy of man with man, out of the desire to help those in sorrow, need and 
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sickness. The first lessons of medicine came to primitive man by injuries, 
accidents, bites of beasts and serpents, perhaps for long ages it is not appreciated by 
his child like mind but, little by little, such experiences crystallized into useful 
knowledge. 
The concept of Siddha system is based on fundamental principles of five 
basic elements of the universe, 96-Thathuvams, three humours and seven thathus 
(physical constituents of the body). The three humours namely vatham, pitham and 
kabam exists in their appropriate ratio. When the harmony of the above said 
humours get deranged owing to a relative increase or decrease of any one or more 
of the principle humours, disease is caused. The alteration in the normal ratio 
produces diseases. The sign and symptoms are produced according to the particular 
deranged kuttrams. 
The intention of this attempt was to bring forth a study depicting the origin, 
growth and efficacy, authorship for each principle or method or receipt of Siddha 
medicine and to provide a step by step evaluation of its growth. A comparative 
study with other system of medicine and an analysis based on the results of those 
studies will help us to prove the principles on which the system stands. 
It is needless to say that the science of medicine is one of the fundamental 
requirements to mankind for its well being and survival. 
Siddha is the oldest, complete, internally consistent system of medicine in 
the world and considered by many to be the mother of all medicine. Pride of  the 
earliest origin of Indian system of medicine is well understood from the earliest 
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literature on Indian medical practice which seems to be appeared during the Vedic 
period in India from the early Iron Age. 
The ultimate aim of every system of medicine is to give health to an 
individual. In these the Siddha System of medicine differs from other system of 
medicine by giving complete physical, mental and social well being of an 
individual by its various tools like medicine, meditation, yoga, varmam, massage 
and its unique social and preventive medicine which is quoted by Theraiyar  in 
‘Pini anuga vithi’ 
“Health is a state of complete physical, mental and social well being and 
not merely an absence of disease” is the widely accepted definition of health given 
by WHO (world health organization). 
Thirumoolar quotes that 
           ‘kWg;gJ cly;Neha; kUe;njndyhFk; 
     kWg;gJ csNeha; kUe;njdr;rhYk; 
            kWg;gJ ,dpNeha; thuhjpUf;f 
            kWg;gJ rhitAk; kUe;njdyhNk.” 
 
It can be thus summarized that the Siddha system is primarily holistic and is 
largely focused on promotive and preventive health. 
 
Knee pain is the commonest symptom seen in people above 40 years which 
affects their daily activities and drives them to consult a doctor. In Palayamkottai 
Government Siddha Hospital the annual consultation rate for knee pain holds the 
Numero Uno position. 
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According to Siddha system of medicine knee pain is the major symptom of 
keel vaayu. The word keel means the hinge joint and the word vaayu means the 
vali or vatham. The increased vali or vatham affects the joint producing knee pain. 
Azhal keel vaayu comes under the 10 classifications of keel vaayu. Azhal keel 
vaayu is characterized by symptoms like joint pain, swelling, tenderness, stiffness 
and restricted movements with a characteristic sound and therefore it can be 
compared with osteo arthritis of knee. 
Osteoarthritis is a chronic degenerative disorder of multi factorial etiology 
characterized by loss of articular cartilage, hypertrophy of bone at the margins, 
subchondral   sclerosis and range of biochemical and morphological alterations of 
the synovial membrane and joint capsule. Typical   clinical symptoms are pain, 
particularly after prolonged activity and weight bearing; whereas stiffness is 
experienced after inactivity. 
 Primary Osteoarthritis is mostly related to aging. It can present as localized, 
generalized or as erosive osteo arthritis. Secondary osteoarthritis is usually 
followed by another disease. It is the second most common rheumatological 
problem and it is the most frequent joint disease with prevalence of 22% to 39% in 
India. Osteoarthritis the most common form of arthritis is a major contributor to 
functional impairment and reduced independence in older adults.  
          The WHO estimates that 70 million Indians are victims of Osteoarthritis, 
nearly 80% of them are elderly. In India 5.3% of males and 4.8% of females are 
aged more than 65 years. Old age cannot be healed or prevented however much can 
be  done by health workers in helping the elderly to lead a normal life, which is 
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necessary for them to perform their activities of daily living(ADL) smoothly. The 
commonest obstacle for elderly to carry out ADL is the problem of joint pain and 
decreased mobility. The prevalence   of this disorder in elderly group is as high as 
85%. This high incidence is the result of its prevalence among menopausal women. 
Shockingly the study conducted by TNS called TNS AROGYA found that 
in the age group 25-35 years, Osteoarthritis figures as the second most prevalent 
disease after diabetes. It also found that there is high incidence of Osteoarthritis, 
because awareness about the disease is very low compared to awareness about 
diseases like diabetes, HIV and cancer. 
Also gastro intestinal toxicity is present in 50% of NSAID users and 5.4% 
develop a more serious event requiring hospitalization due to its frequent use. 
Hence Osteoarthritis represents a major cause of morbidity and disability as well as 
significant economic burden on patients. This study reviews different aspects of 
Osteoarthritis with an emphasis on early treatment with different modalities to 
minimize the major physical, mental, social and economic trauma through Siddha 
system of medicine. 
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AIM AND OBJECTIVES 
 
 
AIM: 
 The aim of this dissertation is to bring out the most acceptable, applicable, 
and affordable drug without the side effects from Siddha system of medicine for 
degenerative diseases like Azhal keel vaayu (osteoarthritis) 
OBJECTIVES: 
1. Primary objectives 
To evaluate the clinical efficacy of Amirtha Kandhi Kukkil Vallathy as 
internal medicine and Ilagu Vida Mutti Thylam as external medicine for the 
disease Azhal keel vaayu (osteoarthritis). 
2. Secondary objectives 
 To study the efficacy of additional therapies like varmam, Thokkanam 
(massage) and asanas in treating the disease along with the internal and 
external medicines. 
 To discuss the various literary evidences in both Siddha and modern text 
books for the diseases Azhal  keel vaayu 
 To confirm the diagnosis in Siddha system with the help of modern 
parameters. 
 To know the extent of correlation of features given under azhal keel 
vaayu with the features of osteoarthritis there by showing the highness 
of siddhars. 
 To know the chemical and phytochemical analysis of the selected drug. 
 To study the Pharmacological analysis of the selected drug. 
16 
 
 To have an idea of an incidence of Azhal  keel vaayu with reference of 
age, sex, Socio economic status, habits and family history related to any 
psychosomatic problems, land where they live (nilam) and climatic 
changes (Paruva  Kalam). 
 To make an awareness among the patients in order to avoid further 
degeneration. 
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SIDDHA ASPECTS 
The concepts of Siddha system are based on fundamental principles of five 
basic elements of the universe, 96 -Thathuvams, three humours and seven thathus 
(Physical constituents of the body). 
Vatham, pitham, kabam are called as three humours of the human system.In 
normal persons these three humours always exist in their appropriate ratio. When 
the harmony of the above said humours gets deranged owing to a relative increase 
or decrease of  any one or more of the principal humours, disease is caused. 
As illustrated in Indian Materia Medica Vol I, The theory of Vatham, 
Pittham and Kabham begins where modern physiology ends.  
The theory of vatham, pitham and kabham was a great discovery, which is 
unfortunately misunderstood by western scholars judging by the wrong mercenary 
translations rendering these terms as wind, bile and phlegm.  
 It must be remembered that the theory of vatham, pitham and kabham not 
only mean the old exploded humoral theory. 
The term, ‘Vatham’ not only simply imply ‘Wind’ but also comprehends all 
the phenomena which comes under the functions of the Central and Sympathetic 
nervous systems and the function of vatham is controlled by central nervous 
system as quoted in the udal thathuvam text book by Prof.Dr.P.M.Venugopal, 
H.P.I.M., 
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Like that, the term ‘Pitham’ not only mean ‘Bile’ but  signifies the 
functions of thermogenesis (or) heat production and metabolism, comprehending 
in its scope the process of digestion, coloration of  blood and formation of   
various secretions and excretions which  are either the means or the end of tissue 
combustion and all these functions are controlled by Autonomous nervous 
system.   
The term ‘Kabham’ not only mean ‘phlegm’ but it is used primarily to 
imply the functions of thermotaxis (or) heat regulations and secondarily 
formation of the various preservative fluids (e.g.) mucus, synovia, and its 
functions are maintained by the cells. 
These principles known as vatham, pitham, and kabham occur, in 2 forms.  
An invisible or essential form, which mainly guide the physiological 
processes pertaining to them naturally. It is called as sookuma thegam in the 
Siddha texts. 
A crude or visible form, the products (as secretions or excretions) of those 
processes induced by these essential forms. It is called as Thoola thegam in the 
Siddha texts. 
The relation between these two forms are very close, so that derangement of 
the essential form of one principle gives rise at once to increased or morbid 
secretions and excretions of that principle 
By knowing these basic principles we can easily study cause, classification, 
diagnosis and treatment of the disease.        
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czT nray; Mfpatw;wpd; khWghLfshy;> Ik;G+jkakhd VO 
clw;jhJf;fshyhd clypw;F tsp> moy;> Iak;> vd;w %d;W caph; 
jhJf;fs; kpFe;Njh Fiwe;Njh Neha; Vw;gbd; Ik;G+j mbg;gilapy; 
cz;lhd mWRitfshyhd kUe;J nghUl;fisf; nfhz;L 
ghpfhpf;fNtz;Lk;. 
 
fPy; thA:- 
rpj;j kUj;Jtj;jpy; vz;gj;J ehd;F tif tsp Neha;fs; gw;wpf; 
$wg;gl;Ls;sJ.  moy; fPy; thA vd;gJ> fPy;thA vd;w jiyg;gpd; fPo; 
$wg;gl;l gj;J tiffSs; xd;W.  fPy;thA vd;gJ %l;Lfspy; Vw;gLk; 
Neha;fisf; Fwpg;gjhFk;.  
According to Sabapathy manuscript Azhal keel vayu comes under the 
classification of ten Keel vayus.  In Keel vayu the mostly deranged factor is 
Vatham.  So Keel vayu comes under the vatha diseases according to thridosha 
theory.  It is also confirmed by Agasthiar in Agasthiar Gunavagadam. 
 
  ‘jhdhf fPy;thj Nuhfk; Ngiu 
  .................................................................................. 
  Neha; jdf;F ghfpaha; thjNuhf nkd;ghH 
  El;gKs;s thjNuhf nkz;gJe; jhd;  
  Ma;e;njLj;J ,jw;Fs;Ns mlf;fk; ghU 
 ..............................................................................” 
-mfj;jpaH Fzthflk; 
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NtW ngah;fs; :-  
 re;Jtyp> %l;Ltyp> Nkf#iy> Klf;F thA> Mkthjk;> re;J thjk;> 
#iyfl;L> re;jpf rpNy\;k Nuhfk;> thj#iy> thANuhfk;.  
             ‘jhdhd fPy;thj Nuhfk; Ngiu  
  rhw;WfpNwd; ePawpa tpgukhf”  
          -mfj;jpah; Fzthflk;.  
fhuz ngah;fs; :- 
 Nehaf; fhuzk;  : Nkf #iy  
 Kf;Fw;w epiy khWghL : thj #iy  
      re;jpf rpNy\;k Nuhfk; 
 ,lj;ijf; nfhz;L : re;J thjk; 
%l;L typ  
      re;J typ  
      Mk thjk; 
 FwpFzq;fisf; nfhz;L : #iyfl;L  
      Klf;Fthjk;.  
Description of the nomenclature 
Azhal keel vaayu    =   Azhal + Keel + Vaayu 
Azhal               =   Pitham 
Keel                  =   Hinge Joint 
Vaayu              =   Vatham 
Initially the joint is affected by the vitiated vatham. Pitham and kabam 
accompany later. It is a disease which is common in pitha kaalam (middle 1/3 of 
the lifespan). 
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Neha; ,ay; : -  
 fPy;thA vd;Dk; tsp NehahdJ typ> tPf;fk;>  Fj;jy;> %l;Lfis 
mirf;f rpukk;> tpiwg;Gj;jd;ik> rpy Neuq;fspy; my;yJ  rpy Neha; 
epiyfspy; Ruk;> grpapd;ik> Nrhif Mfpa FwpFzq;fis cilajhFk;.  
 ‘tspAaike; jd;dpiy nfl;L  
 typAld; tPf;fr; RuKk; fha;e;J 
 %l;Lfs; NjhWk; KLf;fpNa nehe;J  
 %l;Lfs; jd;dpy; ePUk; Rue;J  
 jhq;nfhzh typAkh nehe;jpLkk;Nk” 
           -rghgjp ifNaL.  
 
 
thjKk;> fgKk; jd;dpiy nfLtjhy; %l;Lfspy; typ>  tPf;fk;> 
ePh;Nfhh;j;jy; Mfpait gpwf;fpd;wd.  
Neha; tiffs; : -  
1. tsp fPy; thA  
2. moy; fPy; thA 
3. Ia fPy; thA 
4. tsp moy; fPy; thA 
5. moy; tsp fPy; thA 
6. tsp Ia fPy; thA 
7. moy; Ia fPy; thA 
8. Ia tsp fPy; thA 
9. Ia moy; fPy; thA 
10. Kf;Fw;w fPy; thA  
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nghJthf fPy;thA Neha;fs; tUk; top : 
 czthjp nray;fs;>md;whl gof;ftof;fq;fs;> MkNjhlk;> Rw;Wg;Gw 
#o;epiyfs; Mfpait Kf;Fw;wj;jpy; khWghL Vw;gLj;jp Nehia 
cz;lhf;FfpwJ.  
Environmental factors (Gw #o;epiyfs;): 
       ‘thj th;j;jid fhyNkNjh ntd;dpy;  
 kUTfpd;w Mdp fw;fl khFk;  
 Mjitg; grpNahL fhh;j;jpif jd;dpy;  
 mlUNk kw;w khjq;fs; jd;dpy;  
 NghfNs rkpf;Ffpd;w fhykhFk;” 
 nghUe;jpNa apth; njhopy; jhd; fz;bwj;jy;  
 fhjNt fz;%ly; iffhy; irj;jy;  
 fbe;Njhl;l Klf;fnyhL ePl;lntd;Nd” 
        -A+fp rpe;jhkzp ghly; 245.  
            It is said that the vatha diseases are precipitated in the months from Aani to 
Karthigai (June to December), hence the seasonal factors are involved and 
facilitate the vatha diseases. 
‘gJkj;ijg; G+f;f itf;Fk; ghDkpf;f fhAk; 
KJNtdp ypw;G tpw; ePh; Kw;Wk; - fJnkd 
                   tw;Wk; fg‡Fk; thAkpFk; tho;khe;jh;f; 
                   Fw;w eypf; Nfjpnjd; NwhJ”  
            -kUj;Jth; jdpg;ghly;  
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KJNtdpw; fhyj;jpy;> #hpa ntg;gj;jpd; fhuzkhf ngUk; thhpahf 
ePh; Mtpahf;fg;gl;L G+kpapy; twl;rp epyTk;.  mJNghy; ekJ clypy; twl;rp 
Vw;gl;L tspNeha; tUtjw;F VJthfpwJ. 
 
Diets that increase vatha diseases (czthjp nray;fs;): 
     ‘tspjU fha; fpoq;F tiutpyh japty; Nfhio 
Kspjaph; Nghd;kpFf;F Kiwapyh Tz;b Nfhly; 
Fsph;jU tspapw; Nwfq; Fdpg;Gw Tyty; ngz;bh; 
FspjU kaf;fk; ngw;Nwhh; fbnray; fUtpahkhky;” 
                -rghgjp ifNaL 
 
    ‘njhopy;ngW ifg;Gf; fhh;j;jy;> Jth;j;jy; tpQ;RfpDQ; NrhWk; 
gioajhk; tuF kw;iwg; ige;jpid aUe;jpdhYk; 
vopy;ngwg; gfYwq;fp ,utpdpYwq;fhjjhYk; 
kio epfh; FoypdhNy thjq;Nfh gpf;Fq;fhNz” 
               -guuhr Nrfuk; 
Vatha disease is caused due to the following precipitating factors: 
 Excessive  intake of tubers 
  Excessive  intake of chill foods 
 Wandering in chill air 
 Getting drenched in rain 
 Living in hilly region 
 Excessive sexual intercourse and  
 Heredity 
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 Excessive intake of bitter, astringent, acrid taste food, intake of varagu, 
thinai and altered sleep pattern also contribute to vatha disease. 
 
Habits(epj;jpa nray;fs;):  
    ‘nta;apypy; elf;ifahYk; kpfj; jz;zPh; Fbf;ifahYk;  
nra;apio kfspiur; Nrh;e;jD gtpf;ifahYk;  
igaNd cz;ikahYk; ghfw;fha; jpd;ifahYk; 
ijaNy thjNuhfk; rdpf;Fnkd; wwpe;Jnfhs;Ns” 
            -Njiuah; thflk;  
The factors like, excessive walking in hot sun and excessive intake of bitter  guard 
etc, also disturbs the normal functions of Vatham. 
 
Involvement of Mukkutram i.e. Vatham, Pitham and Kabam: 
   Samanan and viyanan are affected in vatham. In some cases Abanan is 
affected and leads to constipation. 
   In pitham, sathaga pitham is affected. 
   Santhigam is affected in Iyyam. And so Avalambagam is also affected. 
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    Neha; tUk; top 
                                     taJ  
                                    czT 
                              gof;ftof;fq;fs;  
                                 fhykhWghL  
 
 gpj;jk;      thjk;    fgk;  
 rhjfk;    tpahdd;    re;jpfk;  
                                  mghdd; 
    
                                   moy; fPy;thA 
 
thjk; kpF Fzk; :  
‘mwpatpk; %d;wpd; jd;ik nrhd;dhh;ee;jp  
vwpa ey;thj nkwpf;Fq; Fzq;NfS 
Fwpnadf; iffhy; Fisr;R tpyhr;re;J............” 
-jpU%yehadhh; rpfpr;rhuj;djPgk;.  
            thj Nehapy; Fj;jy; typ> re;Jfs; Nehjy;> tapW nghUky;> 
Flypiwr;ry;> kyr;rpf;fy; Nghd;w FwpFzq;fs; Njhd;Wk;.  
        ‘thjtPW md;dkpwq;fhJ fLg;Gz;lhk; tz;zKz;lhk; 
 NkhJfl;F Nuhfk; RuKz;lh kpUkYkh Kwq;fhnjd;Wk; 
 XJjhpa thjkdyhF eLf;fKz;lhk; nghUs; fsah;e;j  
 jPnjdNt euk;gpj;J re;Jfs; NjhWq;fLf;Fe; jpKe;jhNd” 
             -Njiuah; thflk; . 
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thjk; kpFk;NghJ grpapd;ik> cly; fLg;G> Ruk;> ,Uky;> cwf;fkpd;ik> 
cly; eLq;fy;> euk;Gj;jsh;r;rp> re;Jfs; NjhWk; Filjy; Nghd;w 
FwpFzq;fs; NjhWk;.  
 ‘jf;f thA Nfhgpj;jhy; re;Jise;J #iyNehth  
 kpf;f nfhl;lhtp tpl;lq; nfhpA kyq;nfl;Lk; 
 xf;f euk;G jhd; Klq;F kyh;e;J tha; eP&wptUk; 
 kpf;f FspUk; eLf;fkha; Nkdp Fd;wp tUq;fhNd” 
                 -Njiuah; thflk;.  
thjk; kpFk;NghJ %l;Lfs; NjhWk; typ> kpFe;j nfhl;lhtp> 
kyr;rpf;fy;> euk;Gj;jsh;r;rp> tha; ePUwy;> kpff;Fsph;r;rp> cly;  eLf;fy;> 
Nghd;w FwpFzq;fs; Njhd;Wk;.  
Clinical features of Keel Vayu: 
          ‘gpj;j fPy;thA jd;dhw; gpwq;F fPy;Kl;L tPq;fpr;  
rpj;jh; nra; kUj;Jtj;JQ; rPh;glhjd;ikj;jhy;  
jj;jW fha;r;ry; fz;L rhyNt jidjhd; je;Nj 
nkj;jw rpfpr;ir jd;dhy; nkd;Nky; ePf;Fkg;gh” 
                 -rghgjp ifNaL 
 Kl;bfspy; tPf;fk; cz;lhFk;. 
 Kl;bfspy; typ fhzg;gLk;. 
 jPf;Fw;w kpFjpahy; fPy;fspd; gir twz;L> giraw;w fPy; mirAk; 
Nghnjy;yhk; xyp cz;lhFk;.  
 rpy Ntisfspy; fPy;fs; nghUj;Jfs; xd;nwhnlhd;W 
xl;bf;nfhz;L klf;f Kbahky; fhzg;gLk;.  
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Diagnosis in Siddha: 
Piniyari muraigal (Method of Diagnosis) is based upon three main 
principles, 
1) Poriyal Arithal 
2) Pulanal Arithal 
3) Vinaathal   
QhNde;jphpaq;fspd; Ma;T : 
Poriyal Arithal (Inspection): 
  “Poriyal arithal” means examining the “Pori” of the patient by the “Pori” of 
the physician for proper diagnosis. Pori is considered as the “Five sense organs” of 
perception namely, 
1) Mei  (Skin)  
2) Vaai  (Tongue) 
3) Kan  (Eye) 
4) Mookku   (Nose) 
5) Sevi   (Ear) 
 
 
nrtp xypia mwpa nra;jy; ,ay;G 
nka; clypy; Cw;iw mwpjy; Koq;fhy; %l;Lfs;py; tPf;fk>; typ 
fz; xspia mwpa nra;jy; ,ay;G 
ehf;F Ritia mwpa nra;jy; ,ay;G 
%f;F thrid Efu nra;jy; ,ay;G 
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fd;Nke;jphpaq;fspd; Ma;T :- 
tha; trdpf;f nra;Ak; ,ay;G 
if ,LjYk;> Vw;wYk; nra;Ak; ,ay;G 
fhy; elf;fr; nra;Ak; Koq;fhy; %l;Lfs;py; typ> elf;f rpukk; 
vUtha; kyj;ij fopf;Fk; kyr;rpf;fy; 
fUtha; fU> Rf;fpyj;ijf; fopf;Fk; ,ay;G 
 
Pulanal arithal (Palpation): 
             Pulan are five senses. They are, 
1) Smell 
2) Taste 
3) Vision 
4) Sensation of touch 
5) Hearing 
            “Pulanal arithal” means examining the “Pulan” of the patient by the 
Physician to diagnose a disease. 
Vinaathal (Interrogation): 
          Vinaathal is gathering information regarding the history of disease, its 
clinical features etc., from the patient or his/her close relatives usually when the 
patient is not in a position to speak or in the case of a child. 
ENNVAGAI THERVUGAL (Eight diagnostic Tools): 
          It is a unique method of diagnosis in Siddha system of medicine. They are 
clearly explained by the Siddhar Theraiyar. 
31 
 
‘ehb ];ghprk; eh epwk; nkhop tpop 
kyk; %j;jpukpit kUj;JtuhAjk;” 
      -Neha; ehly; Neha; Kjy; ehly; (Kjy; ghfk;) 
1. Naadi (Pulse): 
  In Azhal Keel Vaayu the following Naadi can be seen commonly.   
Vathapitham, Vathakabam, Pithavatham, Pithakabam, Kabavatham. 
2. Sparisam (Sensation to touch): 
         In Azhal keel vaayu mild warmth is noticed over the affected joint and 
crepitus is felt on active movements on the affected knee joint. 
3. Naa (Tongue): 
In Azhal keel vaayu no abnormality is seen in Naa. 
4. Niram (Colour): 
 In Azhal keel vaayu no abnormality is seen in Niram. 
5. Mozhi (Voice): 
In Azhal keel vaayu no abnormality is seen. 
6. Vizhi (Eyes): 
In Azhal keel vaayu no abnormality is seen. As it is a disease of elderly 
population, in some cases, vizhi is found to be altered or affected. 
7. Malam (Faeces): 
In Azhal keel vaayu constipation was reported in some cases. 
8. Moothiram (Urine): 
In urine (Moothiram) Neerkkuri and Neikkuri (Oil on urine sign) 
examination are also done. 
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Neikkuri: 
‘mUe;J khwpujKk; mtpNuhjkjha; 
m..;fy; myh;jy; mfhyT+z; jtph;e;jow; 
Fw;ws tUe;jp cwq;fp itfiw 
Mbf; fyrj; jhtpNa fhJnga; 
njhU K$h;j;jf; fiyf;Fl; gLePhpd; 
epwf;Fwp nea;f;Fwp epUkpj;jy; flNd” 
                   -rpj;j kUj;Jthq;f RUf;fk;. 
Prior to the day of urine examination the patient is instructed to take a 
balanced diet and quantities of food must be proportionate to his routine intake.  
The patient could have no disturbed sleep. After waking up in the morning, 
the first urine voided is collected in a clear wide mouthed glass dish or China clay 
container and is subjected to analysis of “Neerkkuri and Neikkuri” within one and 
a half an hour. 
The collected specimen was examined by the following method. The 
collected urine specimen is kept in a glass dish or china clay container and 
observed under direct sunlight without shaking the vessel. Then drip one drop of 
gingelly oil and observe the spreading pattern and concludes as follows,  
‘muntd ePz;bd..;Nj thjk; 
MopNghw; gutpd; m..;Nj gpj;jk; 
Kj;njhj;J epw;fpd; nkhopt njd; fgNk 
mutpy; MopAk; Mopapy; muTk; 
mutpd; Kj;Jk; Mopapy; Kj;Jk;” 
                                -rpj;j kUj;Jt Neha; ehly; Neha; Kjdhly; jpul;L 
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b. Neerkkuri: 
               ‘te;j ePh;f;fhp nail kzk; Eiu vQ;rnyd; 
iwe;jpa Ysit aiwFJ KiwNa” 
                          -rpj;j kUj;Jthq;f RUf;fk; 
Urine is examined for the following neerkkuri: 
 Niram     -  Colour  
 Edai         - Specific Gravity 
 Manam   -  Smell 
  Nurai       - Frothy nature 
  Enjal        -  Quantity of urine voided 
Apart from these, frequency of urination, abnormal constituents, such as 
sugar, protein, presence of blood, pus, presence of crystals also to be found out. 
         In Azhal keel vaayu straw or hay coloured urine was noticed in Neerkkuri. 
PARUVA KAALAM (Seasonal variations): 
            
          KJNtdpw; fhyj;jpy; ekJ clypy; twl;rp Vw;gl;L tspNeha; 
tUtjw;F VJthfpwJ.  
Sl.No STATE OF KUTTRAM KAALAM 
1. Vatham  thannilai  adaithal 
Munpani kaalam, Pinpani kaalam, koothir 
kaalam, elavenil kaalam 
 2. Vatham thannilai  valarchi 
 
 
 
 
 
valarchi 
Muthuvenil kaalam 
 
3. Vatham vetrunilai valarchi 
 
 
 
valarchi 
Kaarkaalam 
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jpiz (Geographical distribution) 
 FwpQ;rp  : kiyAk; kiy rhh;e;j gFjpAk;  
 Ky;iy  : fhLk; fhL rhh;e;j  gFjpAk;.  
 
 
                ‘Ky;iy epyj;jika Ke;epiu NktpDky;........  
  thjnkhop ahjjDz; kd;D kittopNeha;g;  
  Ngjnkhop ahjiwag; gpd;G” 
 -gjhh;j;j Fz rpe;jhkzp  
 
kUjk;  : taYk; tay; rhh;e;j gFjpAk; 
nea;jy;  : flYk; fly; rhh;e;j gFjpAk;  
 
 
‘nea;jdpy NkYg;ig ePq;fh JwpDkJ..............  
 kUq;Fliy kpf;fhf;Fk; : ty;YWg;ig tPf;Fk;> 
 fUq;Fliyf; fPopwf;Fq; fhz;” 
    -gjhh;j;j Fz rpe;jhkzp.  
 
ghiy : kzYk; kzy; rhh;e;j gFjpAk;.  
Ky;iy kw;Wk; nea;jy; epyq;fspy; thj Neha;fs; ngUkstpy; Vw;gLk;. 
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VO cly; jhJf;fspd; Ma;T : 
SL. 
No 
UDAL 
KATTUKAL 
INCREASED CONDITIONS 
DECREASED 
CONDITIONS 
1. Saaram 
Loss of appetite, excessive 
salivation 
Tiredness, Laziness, 
Diminished activity of 
the sense organs. 
2. Senneer 
Boils and tumours in different                                
Parts of the body, 
Splenomegaly, 
Colic pain, increased blood           
Pressure, reddish eye and skin,                                      
Jaundice, Leprosy, Haematuria 
etc 
 
 
Tiredness, Lassitude,                       
Anaemia 
3. Oon 
Tum urs or extra growth ar und 
the neck, face, abdome , thigh,    
Genitalia etc., 
 
 
 
 
 
 
 
 
Muscle wasting 
 
4. Kozhuppu 
Tumours or extra growth around  
the neck, face, abdomen, thigh,                                          
Genitalia etc., with dyspnoea 
and loss of activity 
Pain 
5. Enbu Strong bones nd teeth 
Weak bones, teeth, 
nails and hair. 
 
 
6. Moolai 
Heaviness, swollen eyes,                                   
Swollen phalanges, oliguria   
non healing ulcers 
Osteoporosis and 
shrunken eyes 
 
 
7. 
Sukkilam or                     
Suronitham 
 
 
Increased sexual activity and 
signs identical to urinary calculi 
Failure to reproduce,                                                  
pain in genitalia 
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In Azhal keel vaayu,  
Saaram, Kozhuppu, Oon and Enbu thathukkal are chiefly affected. 
1. Saaram     :    Weakness, pain in knee joints 
2. Kozhuppu :    Morning stiffness occurs in affected knee joint 
3. Enbu  :    Pain occurring in affected knee joints, crepitations Present.                                                                             
4. Oon  :   Muscle wasting present 
But generally senneer is also affected:  Anemia is found. 
MUKKUTRAM: 
Human body is influenced by Mukkutrams (deranged three humours) i.e. 
Vatham, Pitham and kabam. They are responsible for normal physiological 
conditions of the body. Vatham is mainly responsible for proper loco-motor 
functions. Bones and joints are considered to be the main location of vatham.  
In Azhal keel vaayu the vatha kutram is mainly affected followed by pitham 
and kabam. This produces the following signs and symptoms, 
1. Deranged viyanan leads to pain and difficulty in movements. 
2. Deranged Abanan leads to constipation. 
3. Inflammatory changes of the joints, redness and warmth are developed 
due to deranged pitham. 
4. Sathaga pitham gets affected hindering the loco motor functions. 
5. Along with vatham, kabam is also deranged, Santhigam is affected and 
this leads to abnormality in joint movements. 
6. Erosions of bone margin, increased secretion of synovial fluid are 
developed due to deranged kabam. 
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NOI KANIPPU VIVATHAM (DIFFERENTIAL DIAGNOSIS): 
                Azhal keel vaayu is differentiated from the followings diseases: 
1. VALI KEEL VAAYU: 
 ‘typf;Fj;jy; tPf;fq;fhZk; tha;j;njhz;il twl;rp fha;r;ry;  
 jiytyp khh;Jbg;Gj; jhq;nfhzh typ tPf;fe;jhd;  
 epyT fhq;fZf; Fwq;F ePL Njhs; Koq;iff; fhw;fhk; 
 kyf; Flw;fl;L Nth;it thjf;fPy; thA tpjhNk” 
           -rghgjp ifNaL.  
             It is characterized by excruciating pain and swelling involving  knee joints, 
hip joints, elbow joints, shoulder joints and associated with systemic disturbances 
like dryness of mouth, pyrexia, headache, palpitation, constipation and sweating. 
In advanced cases it may affect the heart and produce “Thamaraga vaayu”. 
 
 
NAME LOCATION PHYSIOLOGICAL FUNCTIONS 
Abanan 
Lower abdomen and 
Extremities 
Responsible for urination, defecation and 
parturition, menstruation, ejaculation of the 
sperm. 
Viyanan Heart 
Responsible for movements of all parts of the 
body and sensation. 
Samanan Stomach Responsible for proper   digestion 
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2. IYA KEEL VAAYU: 
    ‘fUjUq; fgf;fpy; thA fz;bbd; clypisf;Fk;  
 cUnkypthf;Fq; nfhs;Sk; cz;biar; RUf;F kpdge;  
 jUJapy; ePq;F Kl;bw; whq;nfhzh tYitahf;Fk; 
 ,UkNy tpf;fy; the;jp> Nrhig ghz;nlOg;Gk; ghNu” 
               -rghgjp ifNaL  
             It is characterized by severe pain in the joints associated with emaciation 
of the body, anorexia, insomnia, cough, hiccough, vomiting, anaemia and dropsy. 
The common sites are spinal cord, hip joints and knee joints. 
3. VALI IYA KEEL VAAYU: 
 
    ‘mitak; thjf; fgf;fPy; thAthd; typ kpFe;Nj  
 caq;F ePh; Nfhj;J fPy;fs; xhpapd; jiyNghw; fhZk; 
 eaq;nfhs;s Klf;fy; ePl;ly; ez;zplhnka;Aq;fhAk;> 
 kaf;FW Kwf;kpd;dhk; kd;dpa nehpf;fl;lhNk” 
                 -rghgjp ifNaL.  
         It is characterized by pain in the joints associated with effusions of joint fluid 
and swelling, restricted joint movements, pyrexia, fainting, insomnia, especially in 
knee joint asymmetrically, lymphadenopathy, generalized malaise, atrophy of the 
affected limb etc.  The affected joint looks like “Fox’s Head”. 
LINE OF TREATMENT 
  In Siddha system the main aim of the treatment is to cure Udar pini (due to 
Mukkutram) and Manapini (due to changes in Mukkunam). Treatment is not only 
for perfect healing but also for the prevention and rejuvenation. 
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It is essential to know the disease, the aetiology, the nature of the patient, 
severity of the illness, the seasons and the time of occurrence must be observed 
clearly. 
Line of treatment is as follows: 
1. Kaappu  (Prevention) 
2. Neekkam (Treatment) 
3. Niraivu   (Restoration) 
Thiruvalluvar details the duty of the physicians, i.e. study the disease, study 
the cause, seek subsiding ways and do what is proper and effective. 
KAAPU (Prevention): 
           The prevention methods for Azhal keel vaayu are as follows: 
1. Control the body weight by diet and exercise. 
2. Modify the nature of work which gives stress to a particular joint.  
e.g. - Avoid prolonged standing and long distance walking. 
3. Avoid excess intake of sour, astringent and bitter tasted foods. 
NEEKKAM (Treatment in Siddha): 
The aim of Neekkam is based on 
 To bring the deranged Thodams to normal equilibrium state. 
 To treat the patient with internal medicine and external medicine. 
          First the deranged vatham has to be brought to its normal state by                                                             
giving   purgation. It is mentioned in the following verse, 
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    ‘ tpNurdj;jhy; thjk; jhOk; “ 
    ‘ tkdj;jhy; gpj;jk; jhOk; “ 
    ‘ erpa mQ;rdj;jhy; fgk; jhOk;” 
 To implement required complementary therapies according to 
severity of symptoms. 
1. PURGATIVE: 
In Azhal keel vaayu, vatha kuttram is deranged. So a purgative vellai ennai 
–15ml with hot water in early morning in empty stomach on the first day is given. 
 
2. INTERNAL MEDICINE: 
Amirtha Kandhi Kukkil Vallathy – 5 gm in three divided doses/day were 
given with palm jaggery after food. 
 
 3. EXTERNAL MEDICINE: 
Ilagu Vida Mutti Thylam – External application. 
 
  4. COMPLEMENTARY THERAPIES: (Jiz kUj;Jtk;) 
 Apart from other department, Sirappu maruthuvam department gives equal 
importance to complementary therapies in Siddha system of medicine along with 
its internal and external medicines. There are enormous   complementary therapies 
followed in Siddha system of medicine such as kattu, pattru, Nasiyam, Attai Vidal, 
Thokkanam, Ottradam, Varmam, Asanam, Vedhu etc. 
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The complementary therapies which are taken into account for this study are. 
I. Ottradam (fomentation) 
II. Kattu (Compress) 
III. Varma thokkanam (Varmam massage) 
IV. Thokkanam (General Massage) 
V. Vedhu (Steam bath) 
VI. Asanas. 
 
I. OTTRADAM (fomentation): 
 Ottradam is the application of hot or cold packs or the substance so applied. 
There are various types of ottradam mentioned in the siddha literature. In this 
study 2 types are followed. 
a. Hot fomentation by means of medicated pouches. 
b. Hot fomentation by means of lemon directly. 
a. By means of medicated pouches: 
         Medicated pouches are made up of pieces of leaves from either a single 
plant or different  plants 
        The leaves are commonly taken from 
 Calotropis gigantea (erukku). 
 Vitex negunda ( Nochi). 
 Cardiospermum halicacabum (mudakaruthan). 
 Nuna (Morinda citrifolia). 
 Thaluthalai………etc... 
   Benefits: 
           It reduces pain and swelling. Increases blood circulation. It generally 
corrects the deranged vatha kuttram in the affected joints. 
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b.By means of lemon ( elumichai ottradam): 
            Lemon fruit is made into two equal halves. Each piece is tied to small rope 
directly at the back side or wrapped by a thin piece of dressing gauze to hold the 
piece. It is dipped in the trial drug which is heated in the pan and gently applied on 
the affected joints. 
Benefits: 
          It is usually indicated at the time when the knees are swelled. 
II. KATTU - (compress or Bandage): 
             Kattu is the application of medicine made of botanicals(herbs), inorganic 
substances (Minerals and Pashanam) etc, to the affected area and bandaged. 
Procedure followed in this study: 
          The fresh leaves of any one of the following plants like Vitex negunda 
(nehr;rp), Adathoda  vasica (MlhNjhil), Tamarindus indica (Gsp)  are made 
into small pieces and it is sauted or mere mixed well with the external medicine 
and then it is spread in a piece of cotton which is wrapped along the affected joint 
and bandaged. 
Benefits: 
 It is used in the condition of acute swelling and pain in osteoarthritis due to 
overuse of the knee joint. 
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III. VARMAM MASSAGE: 
Varmam points: 
 Normally there are the points where two bones join or a muscle inserted 
into bone or the blood vessels, or  where nerves are prominent. It can also be 
considered as reflex anatomical points directly related to organs lying within. 
          The therapy of physical manipulations either by applying pressure on the 
varmam points or using massage therapy with specific medicated oils or blowing 
certain medicines in the nose or ear is called as varmam treatment. Varmam points 
are rhythmically tuned by varmam therapists for managing various diseases like 
nerve disorders, arthritis, back pain, spinal problems etc. Varmam points to be 
manipulated for osteoarthritis are as follows: 
1. Mootu Varmam: 
 Location: Anterior surface of the knee joint. 
2. Sandhi Varmam: 
 Location: On either side of the Mootu Varmam 
3. Mozhi poruthu Varmam: 
 Location: Posterior surface of the patella 
4. Asaivu thiru kannu varmam: 
     Location: In the anterior surface, 2 finger breadth sidewards to the knee 
joint. 
5. Pathaippu varmam: 
     Location:   either side of the patella at the posterior surface 
6. Sirattai Varmam: 
      Location:   Present at the patella bone. 
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Massage technique: 
 Generally these points are manipulated by doing pinching movements 
around the patella and also in the posterior aspect as quoted by Shanmugam aasan 
in his text books. 
    Benefits:  
     By doing these acute symptoms are greatly reduced. 
IV. VEDHU: (Steam bath) 
          Vedhu includes both steam inhalation and steam application to either 
localized regions on the whole body below the neck region. Steam bath or warm 
decoction shower is done, by adding fresh herbs, aromatic substances or raw drug 
powders to boiling water. 
The benefits of steam baths include 
 Reducing tension 
 Relaxation of muscle tissue 
 Increasing joint flexibility 
 Detoxification 
 Increasing the circulation 
 Stimulation of the immune system 
 Revitalizing skin and enhancing skin tone 
In this study steam bath is recommended for the patients who are obese, which is 
the main risk factor for osteoarthritis. 
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V. ASANAS: 
            Yogasanas are the well known procedures followed by our great siddhars 
for both preventing the body from degeneration and for curing and regenerate the 
body from ailments. Yogasana are followed as one of the important 
complementary therapy in the line of treatment for many diseases which are 
practiced worldwide now-a - days. 
          In this study the sequences of some simple asanas are practiced for the 
patients on considering the facts like weight bearing or advanced asanas are not 
advised for degeneration diseases and in modern science the exercises practiced 
for osteoarthritis mainly concentrates on strengthening the quadriceps muscle 
which spares the weight on knee joint. 
 The sequence of asanas from simple to advance followed by the patients is. 
 Ukatasanam. 
 Vrksasanam. 
 Vajrasanam. 
 Garudasanam. 
           Generally the asanas which increases the strength of quadriceps femoris 
muscles and increases the stability of knee joints are taken into account. Usually 
asasns are advised only after the relief of symptoms. 
1. UKATASANAM(CHAIR POSE): 
Procedure: Stretch your arms, lengthen the spine and bend your knees and 
move your trunk forward at 45 degrees. 
Benefits: It usually strengthens the muscles of the legs particularly the 
quadriceps femoris. 
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2. VRITSHASANAM (Tree pose): 
         Procedure:  Stand erect with legs together and stretch your arms and fold 
your right leg at the knee and place the sole near the left hip joint. After 
maintaining it for some time, repeat on the other side. 
Benefits: This pose strengthens the leg muscles and develops balance. 
3. VAJRASANAM (Diamond pose): 
Procedure: Fold both the knees, keep the joint with each other and sit on the 
pit formed by the heels, keep the spine, neck and head straight. 
Benefits: This pose increases the flexibility of the knee joint and reduces the 
stiffness of the knee joint. 
4. GARUDASANAM ( Eagle Pose): 
Procedure:  
 From Ukatasanam shift your weight on to the left leg. 
 Bend the right leg, lifting the foot from the floor and cross your right thigh 
over your left. 
 Took the right foot around the left calf. 
 Bring the arms out in front. 
 Cross the left arm over the right and bring the palms to touch. 
 Lift the elbows while keeping the shoulders sliding down the back. 
 Hold 5-10 breaths. 
 Repeat on the other side. 
Benefits: Strengthens legs, improves balance and strengthens the shoulder. 
 
 
52 
 
 
 
 
 
53 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modern literatures 
                             AZHAL KEEL VAAYU  
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MODERN ASPECT 
              ANATOMY OF THE KNEE JOINT 
 Introduction: 
The knee joint is the largest joint in the body, consisting of 4 bones and an 
extensive network of ligaments and muscles. Injuries to the knee joint are amongst 
the most common in sporting activities and understanding the anatomy of the joint 
is fundamental in understanding any subsequent pathology. 
 
Bones of the knee joint: 
The knee is made up of four main bones. The femur (thigh bone), the tibia 
(shin bone), fibula (outer shin bone) and patella (knee cap). The main movements 
of the knee joint occur between the femur, patella and tibia. Each are covered in 
articular cartilage which is an extremely hard, smooth substance designed to 
decrease the frictional forces as movements occurs between the bones. The patella 
lies in an indentation at the lower end of the femur known as the intercondylar 
groove. At the outer surface of the tibia lies the fibula, a long thin bone that travels 
right down to the ankle joint. 
 
The knee joint capsule: 
          The joint capsule is a thick ligamentous structure that surrounds the entire 
knee. Inside this capsule is a specialized membrane known as the synovial 
membrane which provides nourishment to all the surrounding structures. 
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  Other structures include the infrapatellar fat pad and bursa which function 
as cushions to exterior forces on the knee. The capsule itself is strengthened by the 
surrounding ligaments. 
 
 Ligaments of the knee joint: 
The stability of the knee owes greatly to the presence of its ligaments. 
Each has a particular function in helping to maintain optimal knee stability 
in a variety of different positions. Knee joint is supported by various ligaments. 
They are 
1.Fibrous capsule, 2.Ligamentum patellae, 3.Tibial collateral ligament, 
4.Fibular collateral ligament, 5.Oblique popliteal ligament, 6.Arcuate popliteal 
ligament, 7.Anterior cruciate ligament, 8.Posterior cruciate ligament, 9.Medial 
meniscus,  10.Lateral meniscus, 11.Transverse ligament. 
 
Bursae around the knee: 
There are about 13 bursae around the knee.  
I. Anterior - 4 bursae,  
II. Lateral   - 4 bursae,  
III. Medial   - 5 bursae. 
 
Articular Cartilage: 
The ends of the bones in a synovial joint are covered with a layer of 
articular cartilage. This is an avascular tissue that consists of cartilage cells 
(chondrocytes) embedded in a thick matrix of proteoglycans, water, type II 
collagen and smaller amount of other proteins. 
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Menisci (knee cartilage): 
Each knee joints has two crescent- shaped cartilage menisci. These lie on 
the medial and lateral edges of the upper surface of the tibia bone. They are 
essential components, acting as shock absorbers for the knee as well as allowing 
for correct weight distribution between the tibia and the femur. 
 
Muscle groups surrounding the knee joint: 
The two main muscle groups of the knee joint are the quadriceps and the 
hamstrings. Both play a vital role, both moving and stabilizing the knee joint. 
 
Quadriceps muscle: 
The quadriceps muscle group is made up of four different individual 
muscles which join together forming the quadriceps tendon. This thick tendon 
connects the muscle to the patella which in turn connects to the tibia via the 
patellar tendon. Contraction of the quadriceps, pull the patella upwards and leads 
to knee extension. 
 
Hamstrings muscle: 
The Hamstrings muscle function in flexing the knee joint as well as 
providing stability on either side of the joint line. 
 
Movements of knee joint: 
       Flexion, Extension, Medial rotation, Lateral Rotation.  
 
. 
58 
 
RIGHT KNEE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
 
OSTEO ARTHRITIS 
Introduction: 
 
              Osteoarthritis can be defined as a degenerative, non-inflammatory joint 
disease characterized by destruction of articular cartilage and formation of new 
bone at the joint surfaces and margins. However, it is a misnomer and the right 
term is Osteoarthrosis or degenerative joint disease.    
 
 EPIDEMIOLOGY: 
 
            The prevalence of Osteoarthritis rises progressively with age, such that by 
65 years 80% of people have radiographic evidence of osteoarthritis, though only 
25- 30 % are symptomatic. The knee and hip are the principal large joints 
involved; affecting 10- 25% of those aged over 65 years. Even for joints less 
frequently targeted by osteoarthritis, such as the elbow or ankle, osteoarthritis 
remains the most common cause of arthritis. 
Osteoarthritis is a complex disorder with multiple risk factors. Twin and family 
studies show that genetic factors play a major role, particularly for hand and 
generalized Osteoarthritis, but also for hip and knee Osteoarthritis.  
The knee Osteoarthritis is prevalent in all racial groups but hip, hand and 
generalized osteoarthritis are particularly prevalent in Caucasians. 
Osteoarthritis is more prevalent and more commonly symptomatic in 
women, except at the hip where men are equally affected. Trauma is a recognized 
predisposing factor and repetitive adverse loading of joints during occupation or 
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competitive sports also appears important, such as in farmers (hip osteoarthritis) 
miners (knee osteoarthritis) and professional footballers (knee osteoarthritis).  
CLASSIFICATIONS: 
  It could be divided into 2 types 
                  1. Primary or idiopathic osteoarthritis. 
                  2. Secondary osteoarthritis. 
S.No PRIMARY 
OSTEOARTHRITIS 
SECONDARY OSTEOARTHRITIS 
1. Usually limited to one or a 
small number of joints. 
May be limited to a small number of 
joints in injury related or may be in joints. 
throughout body, if disease related 
2. No specific inflammatory or 
metabolic condition known to 
be associated with arthritis is 
present. 
Condition that cause damage to cartilage 
are present, such as  -  Inherited disease of 
iron, calcium or copper storage such as 
hemochromatosis, Hyperparathyroidism 
or Wilson’s disease. 
Neurologic disorder that result in the loss 
of nerve function. 
Congenital disease that cause an 
imbalance in the joints.    
3. No history of specific injury or 
trauma. 
History of injury to joints, such as 
fractures and tears or history of trauma.  
joints, such as repetitive heavy lifting. 
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SITES: 
Common sites of primary osteoarthritis: 
 Apophyseal joint of the cervical spine. 
 Thoraco lumbar spine. 
 First carpometacarpal joint. 
 Distal interphalangeal joint. 
 Patella femoral joint. 
 Tibio femoral joint. 
 First metatarsophalangeal joint. 
Intermediate sites: 
 Acromio clavicular joint 
 Hip joint 
Uncommon sites: 
 Shoulder joint 
 Elbow joint 
 Wrist joint 
 Ankle joint 
 
PATHOGENESIS: 
NORMAL ARTICULAR CARTILAGE: 
Normal cartilage has two main components. One is the extra cellular 
matrix, which is rich in collagens (mainly types II, IX and XI) and proteoglycans 
IX mainly aggrecan. Aggrecan is a central core protein bearing numerous 
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glycosaminoglycans chains of chondroitin sulphate and keratin sulphate, all 
capable of retaining water. 
The second component consists of isolated chondrocytes, which lie in the 
matrix. The matrix component is responsible for the tensile strength and resistance 
to mechanical loading of the articular cartilage.  
 
CHANGES OF NORMAL CARTILAGE TO AGING CARTILAGE: 
Several structural and biochemical changes involving the non collagenous 
component of the matrix occur during aging. These changes alter biochemical 
properties of the cartilage that are essential for the distribution of forces in the 
weight bearing zone. 
Glycosamino glycans are modified qualitatively; they become shorter as the 
cartilage ages. The concentration of type VI keratin sulphate increase during aging, 
to the determent of type IV keratin sulphate. 
These quantitative and qualitative changes in proteoglycans reduce the 
capacity of the molecules to retain water. Thus aging cartilage contains less water, 
which alters the biochemical properties of the cartilage. Fissures that develop 
aging are due to mainly to stress fractures of the collagen network. 
 
Articular Cartilage Changes: 
         Many of the mechanisms responsible for progressive loss of cartilage in 
degenerative joint disease remain unknown, but the process can be divided into 
three over lapping stages as described under. 
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Stages in the development and Progression of Osteoarthritis  
Stage 
I 
Cartilage Matrix Disruption or Alteration : 
Disruption or alteration of the matrix macromolecular framework 
associated with an increase in water concentration may be caused by 
mechanical insults, degradation of matrix macromolecules, or alterations 
of chondrocyte metabolism. Initially, the type II collagen concentration 
remains unchanged, but the collagen meshwork may be damaged, and the 
concentration of aggrecan and the degree of proteoglycans aggregation 
decrease. 
Stage 
II 
Chondrocyte Response to Matrix Disruption or Alteration: 
When chondrocytes detect a disruption or alteration of their matrix they 
can respond by increasing matrix synthesis and degradation and by 
proliferating. Their response may restore the tissue, maintain the tissue in 
an altered state, or increase cartilage volume. They may sustain an 
increased level of activity for years. 
Stage 
III 
Decline In the Chondrocyte Response: 
Failure of the chondrocyte to response to restore or maintain the tissue 
leads to loss of articular cartilage accompanied or preceded by a decline in 
the chondrocytic response. The causes for the decline in chondrocytic 
response remain poorly understood, but it may be partially the result of 
mechanical damage to the tissue, with injury to chondrocytes and a down 
regulation of the chondrocyte response to anabolic cytokines. 
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OSTEOARTHRITIS 
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AETIOLOGY: 
I. PRIMARY CAUSE OF OSTEOARTHRITIS: 
Though exact cause is not known, the following factors are suspected to 
play an important role in the causation of primary osteoarthritis  
1) Endocrine 
2) Post Traumatic 
3) Inflammatory joint disease 
4) Metabolic 
5) Congenital or developmental 
6) Genetic 
7) Neuropathic  and others 
1. ENDOCRINE: 
People with Diabetes may be prone to osteoarthritis. Other endocrine 
problems also may promote development, including acromegaly, hypothyroidism, 
hyper parathyroidism and obesity. 
2. POST TRAUMATIC:  
 
Traumatic causes can be further divided into macro trauma or micro trauma. 
An example of macro trauma is an injury to the joint such as fracture causing the 
bones to line up improperly (mal alignment), lose of stability or damage to 
cartilage. Micro trauma may occur over time (chronically). An example of this 
would be repetitive movements or the overuse noted in several occupations. 
3. INFLAMMATORY JOINT DISEASE: 
This category would include infected joints, chronic gouty arthritis and 
rheumatoid disease. 
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4. METABOLIC: 
Disease causing errors of metabolism may cause osteoarthritis. Examples 
include Paget’s disease and Wilson’s disease. 
5. CONGENITAL OR DEVELOPMENTAL: 
Abnormal anatomy such as unequal length of legs may be a cause of 
osteoarthritis. 
6. GENETIC: 
A genetic defect may promote breakdown of the protective architecture of 
cartilage. Examples include collagen disturbances such as Ehlers- Danlos 
Syndrome. 
7. NEUROPATHIC: 
Diseases such as Diabetes can cause nerve problems. The loss of sensation 
may affect how the body knows the position and condition of the joints or limbs. 
In other words, the body can’t tell when it is injured. 
8. OTHERS: 
Nutritional problems may cause osteoarthritis.  
II. SECONDARY CAUSES OF OSTEOARTHRITIS: 
        The causes for secondary osteoarthritis of the knee are as follows: 
 Obesity 
 Valgus and varus deformities of the knee. 
 Intra – articular fractures of the knee, etc. 
 Rheumatoid arthritis, infection, trauma, TB, etc. 
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 Hyper parathyroidism. 
 Hemophilia. 
 Syringomyelia  
 Overuse of intra- articular steroid therapy. 
 It is generally observed that secondary osteoarthritis occurs in the younger 
age groups and is more severe than the primary. Apart from all the features of 
osteoarthritis, secondary osteoarthritis has the features of the corresponding 
aetiological condition. 
 
SIGNS AND SYMPTOMS: 
 The most common signs and symptoms of osteoarthritis are; 
 Predominant symptom is pain which decreases on walking. The pain is 
poorly localized and dull aching in nature. 
  The patient complains of early morning stiffness which subsides over the 
day after activity.  
 Morning stiffness, which usually lasts no more than 30 minutes. 
  Swelling of the joints 
 Minimal tenderness 
 Restricted range of joint movements 
 Coarse crepitus can be elicited 
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Examination of knee joint 
Examination Normal Person Knee Osteoarthritis patient 
In
sp
ec
ti
on
 
Skin 
Colour 
Normal skin 
colour 
Redness due to inflammation 
(if acute) 
Shininess Absent Present due to swelling 
Swelling Absent Present around the joint line. 
Deformity Absent 
Typical varus deformity may be 
present due to marked tibio-
femoral osteoarthritis. 
Gait Normal Gait 
A jerky, asymmetric 
'antalgic' gait due to pain. 
Muscle wasting Absent 
Quadriceps muscle wasting 
may be present. 
Pa
lp
at
io
n 
Warmthness Absent Present due to inflammation 
Effusion 
 
  
a.Patellar tap test Absent Present 
b.Massage test Negative 
Positive in moderate size  
effusion 
 Tenderness Absent 
Joint line or periarticular 
tenderness present (Tibio 
femoral joint line, patello 
femoral joint) 
 Crepitations Absent 
Present due to rough articular 
surface. 
Bony enlargement Absent Osteophytes may be palpable. 
Nodules Absent Loose bodies may be felt. 
 Measurements of 
muscle girth (10cm 
above the patella) 
Normal 
Quadriceps muscle wasting 
may be present. 
 Movement     
a. Extension Normal May be restricted 
b. Extensor lag Absent 
Present due to quadriceps 
muscle weakness 
c. Flexion ( Measure 
the range of active 
flexion using a 
goniometer) 
Normal range 
of movement 
(0-140 degrees) 
Flexion deformity present 
(15-110 degrees) 
69 
 
Te
st
 to
 fi
nd
 li
ga
m
en
tu
m
 
in
ju
ri
es
: 
Anterior Cruciate 
ligament injury 
a.Anterior drawer test 
b.   Lachman's test 
Negative 
Positive if ACL injury present 
Positive if ACL injury present 
Posterior Cruciate 
Ligament injury 
Posterior drawer test 
Negative 
Positive if PCL injury present 
Meniscus tear 
McMurray's test 
Negative 
Positive if Meniscus tear present 
 
 
DIAGNOSIS: 
There is no single sign, symptom or test result that allows a definitive 
diagnosis of osteoarthritis. Instead the diagnosis is based on a consideration of 
several factors, including the presence of the characteristic signs and symptoms of 
osteoarthritis, physical examination and the results of laboratory tests and x-rays. 
 
DIAGNOSTIC CRITERIA: 
Formal criteria helpful for diagnosis of osteoarthritis in synovial joints: 
 Age greater than 40 years. 
 Pain and swelling in knee joint 
 Morning stiffness lasting less than 30 minutes. 
 Crackling sensation (crepitus) present in knee joint. 
 Joint- line or periarticular tenderness.  
 Bony swelling (Osteophytes) around joint margins. 
 Restricted joint movements 
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Clinical variants:  
Monoarticular and pauciarticular OA: 
Underlying abnormality acetabular dysplasia, old Perthe's disease or slipped 
epiphysis, a previous fracture or damage to ligaments or menisci. 
Polyarticular Osteoarthritis: 
Pain, swelling and stiffness of the finger joints, the first carpometacarpal 
and big toe metatarsophalangeal joints or the knees and lumbar facet joints may be 
affected. 
          Long standing cases, osteophytes and soft tissue swelling produce a 
characteristic knobby appearance of the distal inter phalangeal joints (Heberden's 
node) and less often the proximal interphalangeal joints (Bouchard's nodes). 
Endemic Osteoarthritis: 
Osteoarthritis occasionally occurs as endemic disorder affecting entire 
communities. It may either due to some environmental factor peculiar to that 
region or to an underlying generalized dysplasia in a genetically isolated 
community. 
 
DIFFERENTIAL DIAGNOSIS: 
Avascular necrosis: 
          Idiopathic necrosis causes joint pain and local effusion. Early on the 
diagnosis is made by MRI. Once bone destruction occurs the X-ray changes can be 
mistaken for those of Osteoarthritis.  The cardinal distinguishing features is that in 
osteonecrosis is the 'joint space' (articular cartilage) is preserved in face of 
progressive bone collapse and deformity. 
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Inflammatory Arthropathies: 
 
Rheumatoid arthritis, Ankylosing spondylitis and Reiter's disease may start 
in one or two large joints. X-rays show a atrophic or erosive arthritis. 
 
Polyarthritis of the fingers: 
 
Polyarthritis Osteoarthritis may be confused with other disorders which 
affect the finger joints. 'Nodal Osteoarthritis ' affects predominantly the distal 
joints, "Rheumatoid Arthritis" the proximal joints and "Psoriatic arthritis" is a 
purely destructive arthropathy and there are no inter phalangeal nodes. Tophaceous 
gout may cause knobbly fingers, but the knobs are tophi, not osteophytes.  
 
DISH: Diffuse Idiopathic Skeletal Hyperostosis  
  
 This is a fairly common disorder of middle aged people, characterized by 
bone proliferation at the ligament and tendon insertions around peripheral joints 
and the intervertebral discs.  On X-ray examination the large bony spurs are easily 
mistaken for osteophytes.  
  
 DISH & osteoarthritis often appear together but DISH is not osteoarthritis, 
the bone spurs are symmetrically distributed especially along the pelvic apophyses 
and throughout the vertebral column.  When DISH occurs by itself it is usually 
asymptomatic.  
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COMPLICATIONS OF OSTEOARTHRITIS: 
The major complications of osteoarthritis of knee 
 Joint deformities 
 Subluxation  
 Ankylosis  
 Intra- articular loose bodies 
Life style effects include 
 Depression 
 Anxiety 
 Feelings of helplessness 
 Limits on daily activities 
 Job limitations 
 Loss of everyday family joys and responsibilities. 
Laboratory Findings: 
Regarding osteoarthritis laboratory findings are not diagnostic. But, specific 
laboratory test to know underlying causes of secondary osteoarthritis. 
Radiographic features: 
Characteristic finding: 
 Asymmetric loss of cartilage (narrowing of joint space) 
 Sclerosis of subchondral bone under the area of cartilage loss. 
 Cyst close to articular surface 
 Osteophytes at the margin of the joints 
 Osteochondral loose bodies as intra articular bony fragments 
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Others: 
 Old fracture which leads to osteoarthritis 
 Evidence of congenital defects 
 Chondrocalcinosis 
 Later stage displacement of joints 
 If severe, bone destruction 
 
Radiological Classification of Osteoarthritis knee (Ahlbach) AP weight 
bearing and lateral Views. 
 Type I -         Joint space narrowing. 
 Type II -         Total loss of joint space 
 Type III       -    < 5 mm tibial erosion but posterior part of the Plateau  
            intact. 
 Type IV       -         > 5 mm tibial and posterior plateau erosion. 
 Type V        -     Subluxation Note: Grades IV and V: Total knee         
replacement is the line of treatment. 
 
 Radio isotope bone scans shows discrete increased uptake in osteoarthritis 
joints due to bone remodeling. 
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Materials and methods 
                                         AZHAL KEEL VAAYU 
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MATERIALS AND METHODS 
This pilot study to evaluate the efficacy of Amirtha Kandhi Kukkil Vallathy 
(Internal medicine) and Ilagu Vida Mutti Thylam (external medicine) for Azhal 
Keel Vaayu (osteoarthritis) was carried out at post graduate department of sirappu 
maruthuvam , Government Siddha Medical College and hospital, Palayamkottai 
under the observation and guidance of the head of the department. In this study 20 
cases were admitted in in-patient ward and the other 20 cases were seen in Out-
patient ward. 
Selection of cases: 
Certain inclusive Criteria were followed for the selection of cases as 
follows. 
 Sex- both male and female. 
 Patents having symptoms of arthritis of Knee joints, swelling, stiffness, 
crepitations, restricted movements of knee joints. 
 Patients who are willing to undergo radiological investigation and give 
blood for laboratory investigations. 
 Patients willing to sign the informed consent stating that he/she will 
consciously stick to the treatment during 48 days. 
Diagnosis of the cases: 
         Diagnosis was made by conducting all the necessary investigations in siddha 
and by thorough clinical examination and laboratory findings as per modern 
medicine methodology. 
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In siddha system the following aspect were taken into consideration: 
1. Poriyal arithal 
2. Pulanal arithal 
3. Vinaathal 
4. Examination of uyir thathukkal 
5. Ennvagai thervugal 
6. Udal thathukalin Nilaigal 
7. Neerkuri, Neikuri. 
The following Investigations were done in Modern medicine methodology: 
Hematological Investigations: 
a) Total WBC count  
b) Differential WBC count 
c)  Erythrocyte sedimentation Rate 
d) Hemoglobin percentage 
e) Blood sugar 
f)  Blood urea 
g) Serum cholesterol 
Urine analysis: 
a) Albumin 
b) Sugar 
c)  Deposits 
 
Stools examination 
a) Ova 
b)  Cyst 
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Special Investigations 
 X-ray of the affected joint 
 
Selection of drugs 
 Selection of drugs was made from the elaborate study of various siddha 
literatures and finally the drugs were selected from Agathiyar Vallathy 600 and 
siddha vaithiya thirattu. 
 
The trial drugs selected are 
I. Amirtha Kandhi Kukkil Vallathy as internal medicine and  
II. Ilagu Vida Mutti Thylam as external medicine. 
 
LINE OF TREATMENT: 
 The day before the internal medicine started, vellai-ennai was given at early 
morning for purgation to correct the deranged vatham to all the patients. 
 From the second day onwards the trial drugs are administrated. 
 
1. AMIRTHA KANDHI KUKKIL VALLATHY as Internal medicine 
    5gm in three divided doses/day after food 
 
2. ILAGU VIDA MUTTI THYLAM as external medicine 
    This oil was given only for external use on the affected joints. 
           All the patients were advised to maintain dietary regimen (or) pathiyam to 
avoid interaction with drug. 
       Some complementary therapies like ottradam, kattu, Varmam based massage 
and asanas (simple exercises) were manipulated. 
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CLINICAL ASSESSMENTS: 
 The drugs were subjected to phytochemical and Pharmacological analysis. 
 Required information was collected from each patient by using the  forms 
mentioned in protocol. 
 The clinical assessments for In- patients was made daily and recorded. 
  The clinical assessments for out- patients were recorded regularly in each 
visit. 
  A separate case sheet was maintained for each and every patient 
 The laboratory investigation was done before and after treatment and 
recorded in the appropriate form. 
  All the patients were screened for side effects and adverse effects. 
  The outcome is assessed by the reduction of symptoms with the help of 
pain assessment scale. 
 All the patients were advised for the further follow up. 
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Results and observation 
                                                                                                         AZHAL KEEL VAAYU 
 
 
81 
 
OBSERVATION AND RESULTS 
 
1.  Gender distribution 
2.  Age Distribution 
3.  Kaalam distribution 
4.  Occupational Status 
5.  Seasonal variations 
6.  Thinai 
7.  Socio-economic Status 
8. Dietary Habits 
9.  Precipitating Factors 
10. Mode of onset 
11. Clinical features 
12. Other Clinical features 
13. Disturbances in Kanmenthirium 
14. Disturbances in vatham 
15. Disturbances in pitham 
16. Disturbances in kabham 
17.  Udal Kattugal 
18. Ennvagai Thervugal 
19. Selection of patients 
20. Assessments of results 
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1. GENDER DISTRIBUTION: 
 
GENDER NUMBER OF CASES PERCENTAGE 
Male 20 50 
Female 20 50 
Total 40 100 
 
 
 
 
Inference:  
           Among the 40 patients selected for this study, 50% were males and 50% 
were females. 
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2. AGE DISTRIBUTION: 
 
AGE (YEAR) NUMBER OF CASES PERCENTAGE 
31-40 2 5 
41-50 9 22.5 
51-60 & above 29 72.5 
TOTAL 40 100 
    
 
 
 
Inference:  
The prevalence of the disease was found to be higher in the age group of 
51-60 years and above. 
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3. KAALAM DISTRIBUTION: 
 
KAALAM NUMBER OF CASES PERCENTAGE 
Vatha Kaalam 0 0 
Pitha Kaalam 39 97.5 
Kabha Kaalam 1 2.5 
Total 40 100 
 
 
 
 
Inference:  
Out of 40 cases, 97.5 % of the cases were found to be in Pitha kaalam, and 
the remaining 2.5% were found to be in kabha kaalam. 
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4. OCCUPATIONAL STATUS: 
 
OCCUPATION NUMBER OF CASES PERCENTAGE 
Clerical work 4 10 
Teacher 4 10 
Home maker 16 40 
Police 1 2.5 
Driver 2 5 
Farmer & manual labour 13 32.5 
Total 40 100 
 
 
Inference: 
Out of 40 cases, in this study   the rate of incidence is higher in 
occupational group which includes home maker (40%) and farmer & manual 
labour (32.5%) groups. 
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5. SEASONAL VARIATIONS: 
 
SEASONS NUMBER OF CASES PERCENTAGE 
Kaar kaalam (Aug 16 – Oct 15) 24 60 
Koothir kaalam (Oct 16 – Dec 15) 5 12.5 
Munpani kaalam (Dec 16 – Feb15) 0 0 
Pinpani kaalam (Feb 16 – Apr 15) 0 0 
Elavenil kaalam (Apr 16 – June 15) 0 0 
Muthuvenil kaalam (June 16 – Aug 15) 11 27.5 
Total 40 100 
 
Inference:   
          Out of 40 cases, 24 patients (60%) were admitted in Kaar Kaalam, 5 patients 
(12.5%) were admitted in koothir kalam and 11 patients (27.5%) were admitted in 
Muthuvenil Kaalam. 
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6. THINAI: 
 
THINAI NO OF CASES PERCENTAGE 
Kurinji (Hill Area) 1 2.5 
Mullai (Forest Area) 0 0 
Marutham (Fertile Land) 32 80 
Neithal (Coastal Area) 7 17.5 
Paalai  (Desert Land) 0 0 
Total 40 100 
 
 
 
Inference:  
 Among the 40 patients, 1 patient (2.5 %) was from Kurinji, 32 (80%) cases 
were from Marutham and 7 (87.5 %) cases were from Neithal thinai. 
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7.  SOCIO- ECONOMIC STATUS: 
 
CLASS NUMBER OF CASES PERCENTAGE 
Poor 24 60 
Middle class 14 35 
Rich 2 5 
Total 40 100 
 
 
 
 
Inference: Out of 40 cases 60% of cases were poor, 35% cases were from middle 
class and the remaining 5% were rich. 
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8. DIETARY HABITS 
 
Dietary Habits No of Cases Percentage 
Vegetarian 4 10 
Mixed diet 36 90 
 
 
 
Observation: 
All the cases except four were mixed diet. 
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9.  PRECIPITATING FACTORS: 
 
PRECIPITATING FACTORS NO OF CASES PERCENTAGE 
Obesity 12 30 
Menopause 7 17.5 
Occupation related  
 (over use of the joint) 
21 52.5 
H/o trauma 0 0 
H/o fractures 0 0 
 
 
 
  Inference: 
Among the 40 patients, 21 of them (52.5%) were overweight, 12 of them 
(30%) had the history of over use of the joint and 7 (17.5 %) of them were in the 
post menopausal stage. 
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10.MODE OF ONSET: 
 
MODE OF ONSET NO. OF CASES PERCENTAGE 
Acute 0 0 
Gradual 40 100 
 
 
Inference: 
 According to this study 100% of cases were reported gradual onset of 
disease. 
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11. CLINICAL FEATURES: 
 
CLINICAL FEATURES NO. OF CASES PERCENTAGE 
Pain 40 100 
Swelling 23 57.5 
Tenderness 40 100 
Morning stiffness 21 52.5 
Crepitations 40 100 
Deformity 4 10 
Restricted movements 40 100 
 
 
Inference: 
 Among the forty cases all of them had pain, tenderness, crepitations and 
restricted movements. 23 patients had swelling and 21 patients had morning 
stiffness. 
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12. OTHER GENERAL CLINICAL FEATURES: 
 
CLINICAL FEATURES NO. OF CASES PERCENTAGE 
CONSTIPATION 12 30 
PROBLEMS IN EYE SIGHT 4 10 
COUGH 2 5 
INSOMNIA 6 15 
ANEMIA 12 30 
EPIGASTRIC PAIN 8 20 
 
 
 
   Inference: 
Among 40 patients, 12 had constipation, 4 had problems in eye sight, 2 had 
cough, 6 had sleep disturbances, 8 had epigastric pain and 12 were anemic. 
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13. DISTURBANCES IN KANMENTHIRIUM: 
 
   KANMENTHIRIUM NO. OF CASES PERCENTAGE 
Vaai 0 0 
Kai 0 0 
Kaal 40 100 
Eruvai 12 30 
Karuvai 0 0 
 
 
 
Inference: 
 Among the all kanmenthiriums (kai, kaal, vaai, eruvai, karuvai) Kaal was 
affected in all the 40 cases (100 %). And eruvai was affected in 12 cases(30%). 
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14. TABLE SHOWING THE DERANGEMENT OF VATHAM: 
 
VATHAM NO. OF CASES PERCENTAGE 
Pranan 0 0 
Abanan 12 30 
Viyanan 40 100 
Udhanan 0 0 
Samanan 40 100 
Naagan 0 0 
Koorman 4 10 
Kirukaran 2 5 
Devathathan 6 15 
Dhananjeyan 0 0 
 
 
Inference: 
    Viyanan and Samanan were affected in all the 40 cases (100%), Abanan 
was affected in 12 cases (60%),Devathathan was affected in 6 cases (40%), 
Koorman was affected in 4 cases (10%) and kirukaran was affected in 2 
cases(5%). 
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15. DISTUBRANCES IN PITHAM: 
 
PITHAM NO. OF CASES PERCENTAGE 
Analapitham 0 0 
Ranjagam 12 30 
Saathagam 40 100  
Prasagam 0 0 
Alosagam 4 10 
 
 
 
Inference:  
Saathaga Pitham was affected in all 40 cases (100%), ranjaga pitham was 
affected in 12 cases (30%) and Alosagam was affected in 4 cases (10%). 
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16. TABLE SHOWING THE DERANGEMENT OF KABHAM: 
 
KABHAM NO. OF CASES PERCENTAGE 
Avalambagam 40 100 
Kilethagam 0 0 
Pothagam 0 0 
Tharpagam 0 0 
Santhigam 40 100 
 
 
 
 
Inference: 
      In all the 40 cases (100%) Santhigam was affected and so Avalambagam was 
also affected.  
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17. TABLE SHOWING THE CONDITION OF UDAL KATTUGAL: 
UDAL KATTUGAL NO. OF CASES PERCENTAGE 
Saaram 40 100 
Senneer 12 30 
Oon 40 100 
Kozhuppu 40 100 
Enbu 40 100 
Moolai 0 0 
Venneer/suronitham 0 0 
 
 
 
 
Inference: 
 In all the cases Saaram, Oon, Kozhuppu and Enbu were affected (100%) 
and Senneer was affected in 12cases (30%). 
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18. ENNVAGAI THERVUGAL: 
 
ENNVAGAI THERVUGAL NO. OF CASES PERCENTAGE 
Sparisam 40 100 
Naa 12 30 
Niram 0 0 
Mozhi 0 0 
Vizhi 4 10 
Malam 12 30 
Moothiram 0 0 
Naadi 40 100 
 
Naadi  - Pitha Vatham 20 cases (50%) 
Vatha Pitham 16 cases (40%) 
    Pitham Kabham 4 cases (10%) 
 
Inference:     
       Sparisam was affected in all the 40 cases, Naa was affected in 12 cases (30%), 
Malam was affected in 12 cases (30%) & vizhi was affected in 4 cases (10%). 
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19. SELECTION OF PATIENTS: 
 
TREATMENT  OPTIONS NO OF PATIENTS 
Trial drugs only 20 
Trial drugs + Complementary therapies 20 
 
 
Inference:     
This Clinical study includes 40 Patients, i.e. 20 from IP ward and 20 
Patients from OP ward, out of this 10 Patients from InPatient Department and 10 
Patients from OutPatient Department were selected for treating with both trial 
drugs and complementary therapies, based upon their severity. 
 
20. ASSESSMENT OF RESULTS: 
OUTCOME ASSESSMENT SCALE: 
Clinical efficacy of the trial drugs were assessed by the following scales  
Universal pain assessment scale    (Mccaffiry et al., 1993) 
a) 0  No pain 
b) 1-3 Mild Pain 
c) 4-6 Moderate Pain 
d) 7-10 Severe Pain 
50%
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A). ASSESSMENT OF CURATIVE EFFECTS IN KNEE 
OSTEOARTHRITIS PATIENTS TREATED ONLY WITH TRIAL DRUGS: 
SYMPTOMS 
INITIAL READINGS FINAL READINGS 
NO OF 
PATIENTS 
PERCENTAGE 
NO OF 
PATIENTS 
PERCENTAGE 
No Pain 0 0 3 15 
Mild 3 15 9 45 
Moderate 7 35 7 35 
Severe 10 50 1 5 
 
 
Inference: 
                Among the patients who were selected for treating alone with trial drugs, 
10 of them had severe symptoms, 7 had moderate symptoms, and the remaining 3 
patients had mild symptoms. But after treatment only 1 had severe symptoms, 7 
had moderate symptoms, 9 had mild symptoms and 3 had no clinical 
manifestations. 
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B). EFFECT OF TRIAL DRUG ALONE: 
Effect of therapy is assessed from the above tabulated data. 
Effect of the Therapy No. of Patients Percentage 
Good 3 15 
Moderate 9 45 
Mild 7 35 
No 1 5 
 
 
Inference: 
         By treating alone with trial drugs, 15% of patients had good improvement, 
45% of patients had moderate improvement, 35% had mild improvement, and 5% 
had no improvement. 
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C). ASSESSMENT OF CURATIVE EFFECTS IN OSTEOARTHRITIS 
PATIENTS TREATED WITH TRIAL DRUGS ALONG WITH 
COMPLEMENTARY THERAPIES. 
 
SYMPTOMS 
INITIAL READINGS FINAL READINGS 
NO. OF 
PATIENTS 
PERCENTAGE 
NO. OF 
PATIENTS 
PERCENTAGE 
No Pain 0 0 8 40 
Mild 1 5 11 55 
Moderate 9 45 1 5 
Severe 10 50 0 0 
 
 
Inference: 
           Among the patients who were selected for treating both with trial drugs and 
complementary therapies, 10 of them had severe symptoms, 9 had moderate 
symptoms, and the remaining 1 patient had mild symptoms. But after treatment 8 
had no clinical manifestations, 11 had only mild symptoms and the remaining 1 
had moderate symptoms. No cases reported to have severe symptoms. 
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D). EFFECT OF TRIAL DRUG ALONG WITH COMPLEMENTARY 
THERAPIES: 
 
EFFECT OF THERAPY NO. OF PATIENTS PERCENTAGE 
Good 8 40 
Moderate 11 55 
Mild 1 5 
No 0 0 
 
 
Inference: 
         By treating both with trial drugs and complementary therapies, 40% of 
patients had good improvement, 55% of patients had moderate improvement and 5 
% only had mild improvement. None were reported to have nil prognosis. 
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E). COMPARISON BETWEEN EFFECTIVE OF TRIAL DRUG AND 
TRIAL DRUG WITH COMPLEMENTARY THERAPIES: 
 
 
F). OVERALL RESULTS AFTER TREATMENT: 
   Based on outcome, effects after treatment was classified into 4 grades as 
MARKED EFFECT: 
 No longer any clinical manifestations. 
 Patient could work and live normally. 
 No recurrence after some months. 
MODERATE EFFECT: 
 Moderate reduction of manifestations. 
 Slight pain after movement. 
MILD EFFECT: 
 Slight reduction in the clinical manifestation.  
 With relapse. 
NO EFFECT: 
       No reduction of pain and tenderness. 
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EFFECT OF THERAPY NO. OF CASES PERCENTAGE 
Marked effect 11 27.5 
Moderate effect 20 50 
Mild effect 8 20 
No effect 1 2.5 
 
 
             
 
Inference: 
         Out of 40 cases, marked improvement was observed in 27.5 % patients, 
moderate improvement in 50 % patients, mild improvement in 20 % patients and 
no improvement was observed in 2.5 % patients. 
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OP AND IP CASES CLINICAL IMPROVEMENT 
Sl. 
No 
OP & IP 
NO 
NAME AGE SEX DOA DOD 
TREATED 
DAYS 
RESULT 
1 1731 MUTHUKUTTY 75 M 4.8.11 30.8.11 26 MILD 
2 1722 VALLIAMMAL 65 F 4.8.11 3.9.11 30 MODERATE 
3 43036 VEERAYYA 55 M 5.8.11 10.9.11 36 MODERATE 
4 43053 SUBRAMANIAN 70 M 7.8.11 3.9.11 27 MILD 
5 43676 SEETHALAKSHMI 35 F 8.8.11 5.9.11 28 MARKED 
6 43662 RAMALAKSHMI 65 F 8.8.11 15.9.11 38 MODERATE 
7 43843 SANKARAN 72 M 9.8.11 10.9.11 32 MILD 
8 44381 VEERAPANDIYAN 57 M 11.8.11 20.9.11 40 MODERATE 
9 1782 SERVARAN 45 M 11.8.11 9.9.11 29 MARKED 
10 1813 LAKSHMI 60 F 15.8.11 15.9.11 31 MODERATE 
11 1811 SHAMUVEL 65 M 15.8.11 18.9.11 34 MARKED 
12 45073 SANGEETHA 49 F 16.8.11 24.9.11 39 MARKED 
13 1831 SUNDARAM 73 M 17.8.11 13.9.11 27 MILD 
14 1895 SHYMALADEVI 63 F 22.8.11 25.9.11 34 MODERATE 
15 46911 JAYAKODI 65 F 25.8.11 4.10.11 40 MILD 
16 47179 KADARMOIDHIN 72 M 26.8.11 24.9.11 29 MODERATE 
17 1956 PECHIAMMAL 60 F 27.8.11 3.10.11 37 MODERATE 
18 47670 MUTHAMMAL 63 F 29.8.11 30.9.11 32 MODERATE 
19 48469 DHURAIRAJ 
VICTOR 
69 M 2.9.11 30.9.11 28 MARKED 
20 2008 SHANTHY 48 F 2.9.11 7.10.11 35 MARKED 
 
108 
 
OP AND IP CASES CLINICAL IMPROVEMENT 
Sl. 
No 
OP & IP 
NO 
NAME AGE SEX DOA DOD 
TREATED 
DAYS 
RESULT 
21 49412 CHELLAMMAL 70 F 7.9.11 10.10.11 33 MILD 
22 49414 PARVATHY 68 F 7.9.11 6.10.11 29 MODERATE 
23 50023 SHANMUGAVELU 60 M 10.9.11 20.10.11 40 MODERATE 
24 50064 PERIAMMAL 53 F 10.9.11 10.10.11 30 MODERATE 
25 51334 PAZHAVESAM 39 M 15.9.11 22.10.11 37 MARKED 
26 2169 RAMALAKSHMI 59 F 16.9.11 20.10.11 34 MODERATE 
27 51590 MAGALINGAM 46 M 17.9.11 22.10.11 35 MARKED 
28 51659 SUBRAMANIYAN 61 M 17.9.11 27.10.11 40 NO EFFECT 
29 52421 INDRA 41 F 21.9.11 21.10.11 30 MARKED 
30 53206 DHINAKARAN 48 M 24.9.11 30.10.11 36 MARKED 
31 2273 LAXMANAN 58 M 24.9.11 1.11.11 38 MODERATE 
32 2310 CHELLAVADIVU 58 F 28.9.11 28.10.11 30 MODERATE 
33 2358 NARAYANAN 57 M 3.10.11 5.11.11 33 MODERATE 
34 56342 PUSHPAM 70 F 10.10.11 18.11.11 39 MILD 
35 2551 KAMACHI 63 F 15.10.11 20.11.11 35 MODERATE 
36 2651 PERIYASAMY 77 M 22.10.11 30.11.11 39 MILD 
37 2869 SELVI 43 F 7.11.11 7.12.11 30 MARKED 
38 2878 LAKSHMI 50 F 11.11.11 21.12.11 40 MODERATE 
39 2928 SUBBAIYA 66 M 16.11.11 15.12.11 29 MODERATE 
40 2936 KAMACHI 50 F 16.11.11 20.12.11 34 MODERATE 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT- OP & IP PATIENTS  
S. 
NO 
0P. 
NO 
TC 
DC ESR Bl.Sugar Bl.Urea Se. Cr 
N L E M 
BT AT 
F PP 
BT AT BT AT 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1. 1731 7900 8000 51 51 44 44 3 4 2 1 40/84 8/16 77 98 124 135 20 21 0.6 0.7 
2. 1722 7800 7900 53 55 42 42 5 3 - - 10/20 4/8 77 80 86 112 21 24 0.7 0.5 
3. 43036 9000 9100 59 60 34 35 7 5 - - 3/6 3/6 95 95 110 130 21 29 0.5 0.4 
4. 43475 7400 7500 59 59 40 40 1 1 - - 24/52 8/16 90 78 117 120 32 26 0.9 0.6 
5. 43676 8200 8800 65 70 32 27 3 3 - - 10/22 8/16 101 110 88 110 28 35 0.6 0.9 
6. 43662 8900 9500 68 70 30 28 2 2 - - 4/9 2/4 95 102 98 125 21 29 0.8 0.7 
7. 43843 8900 10000 67 69 30 30 3 1 - - 2/5 2/4 84 94 82 124 24 36 0.6 0.5 
8. 44381 8000 8100 62 60 32 34 4 4 2 2 10/20 4/8 83 89 97 120 20 27 0.8 0.6 
9. 1782 8000 8100 59 58 40 41 1 1 - - 24/48 8/16 75 90 110 120 33 28 0.8 0.6 
10. 1813 7900 8100 58 60 37 38 3 1 2 1 6/12 4/8 72 80 96 100 15 17 0.6 0.6 
11. 1811 6900 6900 49 49 48 48 3 3 - - 20/40 4/8 65 99 144 115 24 23 0.7 0.6 
12. 45073 7800 7800 60 61 38 37 2 1 - - 8/16 4/8 74 80 100 128 17 20 0.6 0.5 
13. 1831 8300 8300 58 59 40 39 2 1 - - 10/20 4/8 85 90 110 115 40 36 0.9 0.7 
14. 1895 8300 8300 66 68 30 30 4 2 - - 6/12 4/8 92 95 105 113 31 28 0.8 0.6 
15. 46911 7500 8500 56 60 42 38 4 2 - - 4/9 1/5 73 88 88 105 26 26 0.5 0.8 
16. 47179 7600 9000 68 70 30 28 2 2 - - 8/15 4/10 85 98 95 110 30 34 0.6 0.6 
17. 1956 9500 10500 63 60 27 35 10 5 - - 2/4 1/3 120 110 110 130 25 25 0.9 0.8 
18. 47670 8900 9800 53 55 39 38 8 7 - - 2/4 1/5 131 120 79 109 30 19 0.4 0.4 
19. 48469 7600 7700 49 48 47 48 4 4 - - 20/40 8/16 83 88 116 120 29 24 0.8 0.7 
20. 2008 7600 7800 54 60 44 38 2 2 - - 6/12 4/8 77 80 102 115 21 20 0.7 0.8 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT – OP & IP PATIENTS 
 
S. 
NO 
IP. NO 
TC 
DC ESR Bl. Sugar Bl. Urea Se. Cr 
N L E M 
BT AT 
F PP 
BT AT BT AT 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
21. 49412 8000 8500 68 70 30 28 2 2 - - 7/10 5/12 85 90 138 140 25 30 0.6 0.4 
22. 49414 8700 9000 58 60 40 40 2 - - - 15/30 10/22 87 95 88 110 18 28 0.5 0.9 
23. 50023 8700 9500 66 69 30 30 4 1 - - 8/20 8/18 95 95 98 120 22 20 0.7 0.7 
24. 50064 8900 9500 60 60 38 39 2 1 - - 8/16 6/15 90 102 79 98 34 36 0.8 0.8 
25. 51334 9100 10200 57 57 40 39 3 4 - - 5/12 3/18 82 88 110 135 32 28 0.8 0.6 
26. 2169 8800 9500 62 60 34 38 2 2 - - 6/14 5/18 120 120 105 140 28 35 0.5 0.9 
27. 51590 7600 8800 58 58 40 38 2 4 - - 10/20 8/15 86 96 83 99 21 21 0.5 0.7 
28. 51659 7000 8900 59 65 38 32 3 3 - - 2/4 2/4 116 118 98 115 25 19 0.9 0.9 
29. 52421 7900 7900 68 70 26 24 4 4 2 2 10/20 4/8 71 80 91 110 25 23 0.7 0.7 
30. 53206 7200 7300 55 60 42 38 3 2 - - 8/16 4/8 83 95 123 125 20 23 0.7 0.6 
31. 2273 8400 8500 60 61 37 38 3 2 - - 10/20 4/8 112 78 132 125 18 16 0.6 0.7 
32. 2310 7600 7600 59 60 36 35 5 3 - 2 14/28 8/16 82 80 95 120 15 16 0.6 0.6 
33. 2358 7100 7100 60 58 36 38 4 4 - - 20/40 8/16 76 85 98 100 21 20 0.7 0.8 
34. 56342 8200 9200 63 65 33 33 4 2 - - 10/22 9/18 83 103 74 94 33 35 0.4 0.6 
35. 2551 8000 9600 65 70 32 27 3 3 - - 3/6 3/6 83 83 110 125 22 28 0.6 0.4 
36. 2651 8500 9800 60 65 37 34 3 1 - - 15/30 10/20 96 99 126 145 32 26 0.8 0.7 
37. 2869 8800 10300 60 62 35 32 4 5 1 1 10/20 6/15 83 87 99 118 20 29 0.8 0.8 
38. 2878 9000 11000 57 60 39 40 4 - - - 7/18 5/15 82 112 84 106 32 35 0.7 0.6 
39. 2928 7800 8600 57 60 38 36 3 2 2 2 3/7 3/7 78 98 108 124 31 29 0.5 0.9 
40. 2936 8800 9600 64 65 34 35 2 - - - 3/6 2/4 119 120 77 96 24 29 0.4 0.8 
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URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT – OP &  IP PATIENTS0. 
S. 
NO 
IP NO 
URINE MOTION 
Before Treatment After Treatment Before Treatment After Treatment 
Albumin Sugar 
Deposits 
Albumin Sugar 
Deposits 
Ova Cyst Occult blood Ova Cyst Occult blood 
Pus Cells Epi. cells Pus cells Epi. cells 
1. 1731 NIL NIL 1-2 1-2 NIL NIL 2-4 1-2 NIL NIL NIL NIL NIL NIL 
2. 1722 NIL NIL 3-5 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
3. 43036 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
4. 43475 NIL NIL 2-3 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
5. 43676 NIL NIL NIL NIL NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
6. 43662 NIL NIL 4-5     4-5 NIL NIL 0-4 1-5 NIL NIL NIL NIL NIL NIL 
7. 43843 NIL NIL 2-3 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
8. 44381 NIL NIL 1-2 2-4 NIL NIL 0-1 0-4 NIL NIL NIL NIL NIL NIL 
9. 1782 NIL NIL 2-4 4-5 NIL NIL 1-2 1-5 NIL NIL NIL NIL NIL NIL 
10. 1813 NIL NIL 4-5 4-5 NIL NIL 1-4 4-5 NIL NIL NIL NIL NIL NIL 
11. 1811 NIL NIL 1-2 1-2 NIL NIL 0-1 0-1 NIL NIL NIL NIL NIL NIL 
12. 45073 NIL NIL 1-2 1-2 NIL NIL 1-2 0-1 NIL NIL NIL NIL NIL NIL 
13. 1831 NIL NIL 1-2 1-2 NIL NIL 1-2 0-1 NIL NIL NIL NIL NIL NIL 
14. 1895 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
15. 46911 NIL NIL 2-4 4-5 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
16. 47179 NIL NIL 2-4 2-4 NIL NIL 0-1 1-2 NIL NIL NIL NIL NIL NIL 
17. 1956 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
18. 47670 NIL NIL       1-2 2-4 NIL NIL 0-1 0-1 NIL NIL NIL NIL NIL NIL 
19. 48469 NIL NIL 1-2 1-2 NIL NIL 1-2 0-1 NIL NIL NIL NIL NIL NIL 
20. 2008 NIL NIL 1-2 1-2 NIL NIL 2-4 1-2 NIL NIL NIL NIL NIL NIL 
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URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT – OP & IP PATIENTS 
S. 
NO 
OP NO 
URINE MOTION 
Before Treatment After Treatment Before Treatment After Treatment 
Albumin Sugar 
Deposits 
Albumin Sugar 
Deposits 
Ova Cyst Occult blood Ova Cyst Occult blood 
Pus Cells Epi. cells Pus cells Epi. cells 
21. 49412 NIL NIL 4-5 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
22. 49414 NIL NIL 2-4 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
23. 50023 NIL NIL 1-2 1-2 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
24. 50064 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
25. 51334 NIL NIL 2-4 2-4 NIL NIL 2-4 1-2 NIL NIL NIL NIL NIL NIL 
26. 2169 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
27. 51590 NIL NIL 1-2 1-2 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
28. 51659 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
29. 52421 NIL NIL 1-2 1-4 NIL NIL 1-2 2-4 NIL NIL NIL NIL NIL NIL 
30. 53206 NIL NIL 2-4 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
31. 2273 NIL NIL 1-2 2-3 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
32. 2310 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
33. 2358 NIL NIL NIL NIL NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
34. 56342 NIL NIL      1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
35. 2551 NIL NIL 2-4 2-4 NIL NIL 1-2 0-1 NIL NIL NIL NIL NIL NIL 
36. 2651 NIL NIL 1-2 1-2 NIL NIL 1-2 2-3 NIL NIL NIL NIL NIL NIL 
37. 2869 NIL NIL 3-5 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
38. 2878 NIL NIL 2-4 1-2 NIL NIL 1-2 2-3 NIL NIL NIL NIL NIL NIL 
39. 2928 NIL NIL 1-2 2-3 NIL NIL 1-2 2-3 NIL NIL NIL NIL NIL NIL 
40. 2936 NIL NIL 2-4 4-5 NIL NIL 1-2 1-4 NIL NIL NIL NIL NIL NIL 
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Discussion 
                                   AZHAL KEEL VAAYU  
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DISCUSSION 
 
Osteoarthritis is a chronic degenerative disorder of multifactorial etiology 
characterized by loss of articular cartilage, hypertrophy of bone at the margins, etc 
with the biochemical and morphological alterations of the synovial membrane and 
the joint capsule. Knee pain is the commonest symptom seen in people above 40 
years which affects their daily activities and drives them to consult a doctor. 
Osteoarthritis, the most common form of arthritis is a major contributor to 
functional impairment and reduced independence in older adults so with this 
background, the disease osteoarthritis in knee is taken for the study. 
As a pursuit in fulfilling the prime aim of this study the following trial 
drugs for treating the diseases azhal keel vaayu were selected 
1. Amirtha kandhi kukkil vallathy as the internal medicine 
2. Ilagu vida mutti thylam as the external medicine   
 A detailed study of the disease osteoarthritis was done and was correlated to 
the signs and symptoms of azhal keel vaayu mentioned in the siddha literatures. 
In order to fulfill the primary objectives of this study, a complete open 
clinical trial was done with the trial drugs in treating the disease azhal keel vaayu. 
 The clinical evaluation was done as per the protocol and the data were 
collected by using prescribed forms. The disease azhal keel vaayu was studied 
under various criteria to meet the secondary objectives of the study and the results 
were observed and tabulated. The various criteria and the results were discussed 
here under. 
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Gender distribution 
 Equal numbers of male and female patients were voluntarily selected for 
this study so the inference obtained had no significant data. 
Age distribution  
 This study shows high incidence of azhal keel vayu was in above 50 years 
of age. Azhal keel vaayu which is compared with osteoarthritis which is a 
degenerative disease, so the above inference explained it’s significant as the age 
plays an important role upon the degenerative disorder. 
 The result inferred by me coincides with the result obtained from the study 
Brooks .P., (2003). 
Kaalam distribution 
 The higher incidence (97.5%) was found to be in pitha kaalam (34-66 
years). 
Occupational status 
 From the observed result it is found that the rate of incidence is higher in 
occupational group which include home maker (40%) and farmer & manual labour 
(32.5%) group from these result we came to know that may be for women’s, 
occupations which require knee bending and physical demands were generally not 
associated with Osteoarthritis. 
 But among men occupations which combine knee bending and physical 
demands may be an important cause for osteoarthritis knee. 
 The same was observed in the previous studies like Felon DT et al., (1991) 
and MC Williams DF et al., (2011). 
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Seasonal variations 
 From the inferred data it is noted that 24 patients were admitted in 
kaarkaalam 5 patients in Koothirkalam and 11 patients in mudhuvenil kalam. 
 Actually the study period for this clinical trial lies between June -2011 to 
January-2012. So the obtained result may not have a scientific value to influence 
the disease and a long period study is required to evaluate the influence of seasonal 
variations. 
Thinai reference  
 The obtained result shows that incidence was higher in maruthanilam. 
 As this study is a single centered study the obtained results may not have a 
scientific evolution of influence of living lands on osteoarthritis so a thorough 
multicenter study in wide spread areas are needed to evaluate it. 
Socio -economic status 
 Here 60% were reported to be poor and 35% cases were from middle class 
and the remaining 5% were rich. This higher incidence in the poor population may 
be due to over use of the joint by farmers or manual worker and uneducation or 
unawareness about the knee problem among the poor. The incidence in the other 
population group may be due to over - weight. 
 This inferred result coincides with the results of the study by F.Callahan et 
al., (2011). 
Dietary habits  
 36 patients were reported to have mixed diet. So this data has no 
statistically significant data. 
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Precipitating factors: 
 Inferred result proves that the obesity (52.5%) and the occupational relation 
(i.e. over use of the joint) (30%) were the most important precipitating factors. 
 The same inference was obtained from many previous studies like David 
T.Felson MD, MPH et al., (2005). 
Mode of onset: 
 According to this study 100% of cases were reported to had gradual onset 
of disease. Since osteoarthritis is a degenerative disorder it usually has a gradual 
onset of symptoms. 
 Above inferred result well coincides with many of the previous studies like 
David T.Felson M.D, M.Ph., (2005). 
Clinical features 
 From the tabulated data, it was clear that all the patients had pain, 
tenderness, crepitations and restricted movement as their predominating 
symptoms. Then swelling (57.5%) and morning stiffness (52.5%) were found to be 
predominant next to the above symptoms. 
Distribution of Three Thodams 
a) Vatham: 
Samanan and viyanan were found to be affected in all the 40 patients. 
b) Pitham: 
Saathagam was affected in all the cases 
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c) Kabam: 
 In all the cases santhigam was found to be affected and so avalambagam 
was affected in all cases. 
Udal Kattugal: 
Among the seven udal Kattugal, Saaram, Oon, Kozhuppu, enbu were found 
affected in all the cases and senneer was affected in 30% of the cases.  
Ennvagai thervugal: 
 Sparisam (swelling, warmth and crepitation) were found affected in all the 
40 cases.  
            In naadi nadai, pitha vatha naadi (50%) and vatha pitha naadi (40%) 
predominates among the other naadi nadai in the osteoarthritis patients. 
Disturbances in Kanmenthiriums: 
 Kaal was affected in all the 40 cases. 
           Laboratory investigations were done for all the cases before and after 
treatment. There were no significant variations in the laboratory investigation 
except in certain parameters like ESR and Hb. 
 The phytochemical analysis of Amritha Kandhi Kukkil Vallathy melugu 
had shown the presence of chloride, sulphate, Iron (ferrous), starch, tannic acid, 
unsaturated compounds, reducing sugar and amino acid. 
 Pharmacological studies of Amritha Kandhi Kukkil Vallathy show 
significant analgesic, acute anti inflammatory and moderate chronic anti 
inflammatory actions. Ilagu Vida Mutti Thylam had moderate acute-anti 
inflammatory action. 
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Treatment 
 In siddha system of medicine the line of treatment primarily aimed to retain 
the deranged thosams and then providing relief from symptoms so before 
treatment each patient was advised for purgation by giving vellai-ennai-15ml with 
hot water during morning for first day treatment. 
 From the second day onwards Internal medicine -Amirtha kandhi kukkil 
vallathy -5gm in 3 divided doses. 
 External medicine -Ilagu vida mutti thylam were given. 
 During treatment, the patients were advised to follow pathiyam (avoid 
tamarind, tubers etc) and particularly advised to avoid foods which increases 
vatham. 
 Along the course of the treatment, some of the complementary therapies 
which were already planned for the comparison of effects like ottradam, varmam 
massage, asana, steam bath were given additionally to some of the patients. 
 The outcome is mainly assessed by reduction in severity of Joint pain, 
Stiffness and improvement in physical functioning and quality of life. Universal 
pain assessment scale  used to infer proper outcomes. 
 No adverse effect of both internal and external medicine was noted along 
the course of the treatment clinically. 
A Comparison: 
In one similar study of the knee Osteoarthritis, 40 patients were treated with 
ibuprofen 400mg thrice daily. The study lasted four weeks and patients were 
assessed weekly according to a standard pain assessment scale.  
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This clinical trial of osteoarthritis with Ibuprofen shows the results as 15 
(37.5%) showed positive clinical response and 11 (27.5%) improved, with positive 
clinical response taken as a 20% decrease in primary outcome (pain with 
function).Significantly 35% of patients taking ibuprofen suffered side effects, 
mainly gastrointestinal bleeding. 
Using pain scale analysis, a comparative graph is drawn for these two 
clinical trials (AKKT+LVT+CT and IBUPROFEN) 
 
(Note: This Graph shows the effect of individual drugs from different clinical studies.) 
This when compared with our study using a multivariate analysis, showed 
no significant difference of outcome. (P value 0.6544) 
(Note: This analysis shows the effect of individual drugs from different clinical 
studies for the sake of comparison only.) 
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These shows, 
• In the case of Osteoarthritis, Amirtha Kandhi Kukil Vallathy and Ilagu 
Vida Mutti Thylam along with complementary therapies appears to be as 
effective as a leading NSAID treatment, but with far fewer side effects.  
• Amirtha Kandhi Kukkil Vallathy and Ilagu Vida Mutti Thylam along with 
complementary therapies is non-toxic and is safe for long-term 
administration.  
• Although quick pain relief is achieved using standard drug, our trial drug 
eventually reaches there at the end of the study period. 
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SUMMARY 
 The disease osteoarthritis was comparatively studied with the disease Azhal 
Keel vaayu with reference to its etiology, pathogenesis and clinical features. In 
considering the following facts, that Knee Osteoarthritis is the most common form 
of arthritis (Conagha., 2008); knee Osteoarthritis is the leading cause of chronic 
disability in the elderly population (MMWR orls mortal., 2001) and only 
symptomatic relief with greater side effects (liver damage and gastrointestinal 
bleeding) (Flood J., March 2010) was available in modem science, there is a need 
to evaluate the safe and effective drug for osteoarthritis. So, Amritha Kandhi 
Kukkil Vallathy as internal medicine and Ilagu Vida Mutti Thylam as external 
medicine was selected and a clinical trial in Govt. Siddha Medical College, 
Palayamkottai was conducted with these drugs. For this 40 cases were selected in 
which 20 were treated in OutPatient ward and remaining 20 in InPatient ward. The 
pre clinical studies of the trial drug were found to be encouraging. 
 Pharmacological analysis of amirtha kandhi kukkil valathy shows 
 significant analgesic action 
 significant Acute anti inflammatory action 
 moderate chronic anti inflammatory action. 
Pharmacological analysis of Ilagu vida mutti thylam shows 
 moderate acute anti inflammatory action 
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Since complementary therapies or manual therapies like massage, 
fomentation, exercises plays a significant role in treating osteoarthritis (French HP 
et al., 2011). Some of the complementary therapies from siddha system are 
manipulated along with trial drugs depending upon the severity of the disease. 
 
Daily progress was observed to evaluate the efficacy. The results obtained 
were found to be auspicious. Particularly results by complementary therapies were 
found to be very auspicious. 
 
No adverse reactions were found. Hence the trial drug was found to be safe 
and effective. 
 
 
 
 
 
 
 
 
 
 
 
 
 
125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
                                    AZHAL KEEL VAAYU  
                                                                                                                                    
 
126 
 
CONCLUSION 
In this clinical study “Amritha Kandhi Kukkil Vallathy” and “Ilagu Vida 
Mutti Thylam” were taken as Internal & External drug respectively for treating 
the disease Azhal Keel Vaayu.   
In the pre clinical study Pharmacological evaluation of the trial drugs shows 
 Significant analgesic effect 
 Significant acute anti inflammatory effect 
 Moderate chronic anti inflammatory effect. 
  The Overall results of  efficacy of the trial drugs along with complementary 
therapies by reducing the clinical signs and symptoms like pain, swelling, morning 
stiffness in this Clinical study were  found to have marked effect in 27.5% cases, 
Moderate effect in 50% cases, Mild in 20% cases and no effect in 2.5% cases.  
The costs of the trial medicines were relatively economical. The raw drugs 
are easily available and the preparation was also convenient. No adverse effects 
and side effects were found clinically for the trial drugs.  
So the clinical effect of the trial drugs along with complementary therapies 
was found to be Moderate in treating the disease Azhal keel vaayu (Osteoarthritis). 
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ANNEXURE - I 
STANDARD OPERATING PROCEDURE FOR PREPARATION OF 
AMIRTHA KANTHI KUKKIL VALLATHY  (Internal)   AND ILAGU 
VIDA MUTTI THYLAM (External) 
SOURCE OF RAW DRUGS: 
           The required drugs for preparation of AMIRTHA KANDHI KUKKIL 
VALLATHY (Internal)  and  ILAGU VIDA MUTTI THYLAM (External)  are 
purchased from a well reputed country shop and Raw drugs are Authenticated by 
Medical botanist of Govt. Siddha Medical College, Palayamkottai, then  purified 
and the  medicines are prepared in the  Gunapadam laboratory of Govt. Siddha 
Medical College, Palayamkottai. 
AMIRTHA KANDHI KUKKIL VALLATHY- INTERNAL MEDICINE  
REF: AGATHIYAR VALLATHY 600 
INGREDIENTS:  
Purified kandhagam (Sulphur) 280 gm 
Purified kukkil (Shorea robusta) 140 gm 
Purified serankottai(Semecarpus anacardium) 140 gm 
Seenthil sarkarai (Tinospora cordifolia ) 140 gm 
Purified ell(Sesamum indicum) 140 gm 
Purified amukkura(Withania somnifera) 105 gm 
Purified parangipattai(Smilax chinensis) 105 gm 
Purified kodiveli verpattai(Plumbago zeylanicum) 70 gm 
Valuluvai arisi(Celastrus paniculatus) 35 gm 
Kottam(Costus species) 35 gm 
Valmilagu( Piper cubeba) 35 gm 
Paereechu(Phoenix species) 35 gm 
Sadamanjil(Nardostachys jatamansi) 35 gm 
Sivanarvembu( Indigofera asphalanthoides) 35 gm 
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Vetti ver( Vettiveria zizhinoides) 35 gm 
Vellarugu(Enicostemma axillare) 35 gm 
Sanganguppi(Clerodendron inerme) 35 gm 
Kadukkai thol(Terminalia chebula) 35 gm 
Thandrikkai(Terminalia bellerica) 35 gm 
Nellikai(Emblica officinalis) 35 gm 
Sirunagapoo(Mesua ferra) 35 gm 
Thakkolam (Illicium verum) 35 gm 
Seerakam(Cuminum cyminum ) 35 gm 
Karboki(Psoralea corylifolia) 35 gm 
Karunjeerakam(Nigella sativa) 35 gm 
Thalisapathri(Taxus buccatum) 35 gm 
Nannari(Hemidesmus indica) 35 gm 
Nerunji mul(Tribulus terrestris) 35 gm 
Nilappanai(Curculigo orchioides ) 35 gm 
Thanneervittan kilangu(Asparagus racemosus) 35 gm 
Kothumalli(Coriandrum sativum) 35 gm 
Kalmatham(Asphaltum) 35 gm 
Kalnar(Asbestos) 35 gm 
Elam(Elettaria cardamomum) 35 gm 
Chukku(Zingiber officinale) 35 gm 
Milagu(Piper nigrum) 35 gm 
Thippili(Piper longum) 35 gm 
Karuvappattai(Cinnamomum verum) 35 gm 
Chittrarathai(Alpinia galanga) 35 gm 
Panai vellam(Palm jaggery) 1540 gm 
Then(Honey) 280 gm 
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PURIFICATION OF DRUGS:  
Kandhakam:  
 
Steamed with cow`s urine by placing it underground. Then steaming 
process is repeated with each of onion juice, Solanum nigrum juice, Amaranthus 
tricolor juice, Copper sulphate mixed with curd. 
Kungiliyam:  
 
Fermented with neem bark decoction for three days and washed with cool 
water. Same is repeated with a mixture of butter milk, vinegar, and lime juice. 
Then it is boiled with milk and fried with ghee. 
Serankottai:   
 
Coated with lime stone and fried with vinegar 
Parangipattai and amukura:  
 
Steamed with milk 
Kodiveli:  
 
Steamed with milk 
Other drugs are cleaned and fried slightly and taken 
PREPARATION: 
   The ingredients (except palm jaggerry and honey) are powdered and ground 
with honey and palm jaggerry for 12 hours to a fine consistency.  
 DOSE: 
           5 gm in three divided doses/day. 
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ILAGU VIDA MUTTI THYLAM - EXTERNAL MEDICINE 
Ingredients : 
  
Etti kottai seeval (chips of seeds of Strychnos nux -vomica) - 87.5gms 
Sesamum oil - 2.6lits 
Poondu (Allium sativum) - 87.5gms 
Aayil pattai thugal  (Chips of bark of Holoptelia integrifolia) -62.5gms 
 
Method of preparation: (Ref-Siddha vaithiya thirattu pg no-292) 
 
Soak etti kottai seeval in goat’s milk for 12 hrs. Put all the ingredients in the 
vessel and heat it till the drugs turn to red. Then filter the oil and keep in the 
sunlight then use it for external purposes 
 
 DRUG STORAGE- 
       
 The trial drug Amirtha kandhi kukkil vallathy was stored in clean and dry 
glass bottles.  Ilagu vida mutti thylam was stored in clean and dry narrow mouthed 
bottles. 
1. fe;jfk; (Sulphur): 
   Characters:  Rit :frg;G> Jth;g;G 
TherapeuticActions:Laxative,Cholagogue,Antiseptic,Alterative,Diaphoretic 
nghJFzk; :- 
 ‘ney;ypf;fha;f; fe;jpf;F ePs;gjpndd; Fl;lke;jk;  
  ty;iy ftpir Fd;k thAfz;Nzha; - nghy;yh 
  tplf;fbtd; NkfNeha; tPWRuk; Ngjp 
  jplf;fpuf zPfgk;Nghe; Njh;” 
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2. Ff;FY (Commiphora mukil  -Burseraceae) 
  Parts used       :   Gum resin 
Therapeutic uses :  It has very good anti vatha property. It is a good   
                                    aphrodisiac drug also. 
 
3. Nruhq;nfhl;il (Semecarpus anacardium- Anacardiaceae) 
Parts Used         :  Fruits and seeds 
Therapeutical Actions :    Alterative, Caustic 
 
nghJFzk;: 
‘Nrq;nfhl;il  nka;j;jpkpiuj;jPuhf; fbtplj;ijg; 
gq;nfhl;L %yj;ijg; gw;Wf;Fk; - Mq;nfl;bf; 
nfhy;YkPth ej;jpndhU Fd;kj;ij Ak;kjid 
nty;Yk; mapw;fz;zha; tps;” 
 
4. rPe;jpy; (Tinospora cordifolia-Menispermaceae) 
     Parts used   :  Leaves, stem and rhizome 
  Therapeutic Actions: Alterative, Antiperiodic, Aphrodisiac, Demulcent,    
                                         Stimulant, Stomachic, Tonic, Diuretic. 
 
rPe;jpy; rh;f;fiu nghJFzk;:  
  ‘mKjty;ypf;nfhb af;fhu Kz;blj; 
                jpkpUW NkfNeha;j; jPnayh khWnk”. 
 
5. vs;(Source of Gingelly Oil) (Sesamum indicam-Pedaliaceae) 
Parts used           :   Leaves, flowers, fruits and seeds 
Therapeutic actions:  Demulcent, Laxative, Nutritive, Emollient  
nghJFzk;: 
 ‘Gj;jp eadf; Fsph;r;rp G+hpg;G nka;g;GsfQ; 
  rj;Jtq; fhe;jp jdpapsik nkj;jTz;lhq; 
 fz;Nzha; nrtpNeha; fghy moy; fhrNeha; 
 Gz;Nzha;Ngh nkz;nza;ahw; Nghw;W” 
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6. mKf;fuh - (Withania somnifera- Solanaceae) 
Part used: Dried root.  
 
nghJFzk;: 
         ‘nfhQ;re; Jth;g;ghq; nfhbafak; #iyaup 
     kpQ;Rfug; ghd;ghz;L ntg;gjl;G-tpQ;rp”.  
      - mfj;jpah; Fzthlfk;  
7. gwq;fpg;gl;il (Smilax  chinensis – Liliaceae) 
Part used:   bark  
Therapeutic actions: Alterative, Antisyphilitic, Aphrodisiac, Depurative. 
 
nghJFzk;: 
         jhfk; gythjQ; jhJel;lk; Gz;gpsit  
Nkfq; fbfpue;jp tPo;%ye; - NjfKld; 
Fl;il gfe;jNkw; nfhs;tkdk; Nghk;gwq;fpg; 
gl;ilapid Ar;rhpj;Jg; ghh;. 
 
8. nfhbNtyp (Plumbago zeylanica – Plumbaginaceae)    
Part  used:   Root  
nghJFzk;: 
 ‘fl;btpu zq;fpue;jp fhy;fs; miuahg;Gf;  
 fl;br;# iytPf;fq; fho;%yk; - Kl;b uj;jf;  
        fl;LeP Nuw;wq; fdj;j ngUtapWk;  
 ml;Lq; nfhbNtyp ahk;” 
 
9. thYSit (Celastrus paniculatus- Celastraceae) 
Parts Used        :   Leaves, seeds 
Therapeutic actions: Aphrodisiac, Stimulant, Alterative, Nervine tonic 
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10. Nfhl;lk;-(Costus species -Costaceae) 
Part used: Root 
Therapeutic Actions: Antidiabetic, anti lipidemic, anti oxidant, anti microbial 
11. thy;kpsF( Piper cubeba- Piperaceae) 
Part used          : Dried fruits (berries) 
Therapeutic Actions:     Stimulant,carminative,Diuretic, Expectorant 
12. Nghpr;rq;fha;( Phoenix dactilifera- Arecaceae) 
Part Used                 : fruit,seed,gum,sugar 
Therapeutic Actions: Tonic, Nutritive,  Demulcent,  Laxative, Diuretic 
13. rlhkhQ;rpy; (Nardostachys jatamansi- Valerianaceae) 
Parts used:                    root 
Therapeutic Actions:  Stimulant, Diuretic,  Antispasmodic , Expectorant 
14. rptdhh; Ntk;G( Indigofera aspalanthoides-Fabaceae)  
Parts used:  leaves, stem, flowers and root 
Therapeutic actions: stimulant, demulcent. 
15. ntl;bNth; (Vettiveria zizhinoides- Poaceae) 
Part Used          : Root 
Therapeutic Actions: Tonic, Stimulant, Antispasmodic, Diuretic, Febrifuge. 
16. nts;sWF ( Enicostemma axillare – Gentianaceae)  
Part  used: whole plant 
Therapeutic Actions: stomachic, tonic, Alterative, laxative, febrifuge. 
 
 
139 
 
17. rq;fd; (Azima tetracantha – Salvadoraceae) 
Part used : Root 
Therapeutic actions: diuretic, Stimulant, astringent, tonic, Antiperiodic.  
18. rpWehfg;G+ ( Mesua ferra- Calophyllaceae (Guttiferaceae)) 
Parts used    : Leaves, bud, flower, seeds, root bark, etc 
Therapeutic Actions: Astringent, carminative, Aromatic, Acrid, Purgative 
19. jf;Nfhyk;: 
Parts used: whole plant. 
Therapeutic Actions: Antivatha ,Astringent, Febrifuge, Nutritive. 
20. ew;rPufk;( Cuminum cyminum- Umbelliferae) 
Parts used: seeds  
Therapeutic actions: Carminative, Stimulant, Stomachic, Astringent. 
21. fhh;Nghfuprp (Psoralea corylifolia -  Fabaceae.) 
Part used : The dried fruit  
Therapeutic actions: Laxative, Stimulant.  
22. fUQ;rPufk; (Nigella sativa -  Ranunculaceae) 
Parts used: Seeds 
Therapeutic actions: carminative, Diuretic, emmenagogue, galactogogue,   
                                    anthelmintic, Stomachic, Parasiticide, Emollient. 
23. jhsprgj;jphp  (Taxus buccata- Taxaceae) 
Parts used: leaves 
Therapeutic Actions:     Stomachic, Carminative, Tonic, Expectorant. 
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24. ed;dhhp ( Hemidesmus indicus- Apocynaceae) 
Part used           :  root 
Therapeutic actions :   Alterative, Tonic, Demulcent, Diuretic, Diaphoretic 
25. neUQ;rpKs; (Tribulus terrestris- Zygophyllaccae) 
Parts Used  : Whole plant particularly fruit  
Therapeutic Actions: Refrigerant,diuretic, Demulcent,Aphrodisiac, 
26. epyg;gid (Curculigo orchioides- Hypoxidaccae) 
Parts used        : Rhizomes, roots 
Therapeutic Actions: Tonic, Diuretic, Astringent, Carminative, Emollient 
27. jz;zPh; tpl;lhd; (Asparagus racemosus- Liliaccae) 
Parts used  :  Leaves, Rhizomes 
Therapeutic Actions: Nutritive, demulcent, Galactagogue, Aphrodisiac,  
        Antispasmodic 
28. ky;yp ( Coriandrum sativum – Umbelliferae ) 
Parts used  : Seeds  
Therapeutic actions : Stomachic, Carminative, Stimulant, Diuretic. 
29. Vyf;fha;( Elettaria cardamonum- Zingiberaceae )  
Part used   : Seeds  
Therapeutic actions : Stimulant, Carminative, Stomachic. 
30. Rf;F (Zingiber officinale – Zingiberaceae)  
Part used   :  dry rhizome 
Therapeutic actions: stimulant, Stomachic, Carminative. 
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31. kpsF(Piper nigrum- Piperaceae) 
Part used  : The fully matured dry fruit  
Therapeutic actions: Acrid, Carminative, Antiperiodic,  Stimulant.  
32. jpg;gpyp ( Piper longum – Piperaceae) 
Part used  : The fully matured dry fruit  
Therapeutic actions : Stimulant, Carminative. 
33. fUthg;gl;il( Cinnamomum Verum- Lauraceae) 
      Parts used         :    Bark 
Therapeutic Actions: stimulant, Carminative, Aphrodisiac 
34. rpw;wuj;ij (Alpinia calcarata- Zingiberaceae)  
Part used           : Rhizome 
Therapeutic Actions:  Expectorant, febrifuge, stomachic 
35. gdq;fUg;gl;b(gid) (Borassus flabelliformis-Arecaceae) 
Parts used   : Palm jaggery 
Therapeutic Actions : Astringent, Aphrodisiac, Diuretic, Demulcent,  
                                              Nutrient, Refrigerant,Stimulant, Antiphlogistic  
36. Njd; (Honey)  
 
‘mDghd kha;g;gpd; mtpo;jKkha;j; Njhd;wp 
fdkhd Njfepiy fhl;bg;- gpDNk 
aurd; Kjy;Nth iuAkhl;L tpj;jhNy 
gurj; jpdhw;Nghk; gpzp” 
      -Njud; nghUl;gz;G Ehy; 
Njd; clypy; thjKjypa Kf;Fw;wq;fisg; Nghf;fp Njfj;ij 
ed;dpiyapy; itf;Fk;. 
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37. fy;ehH (ASBESTOS) 
 Asbestos is a curious natural white rock consisting of calcium silicate. It is 
found in large quantities near the town of Mysore. 
Therapeutic Actions: Diuretic, Astringent.  
 
38. fy;kjk; (Asphaltum) 
Synonyms :    Nfh%j;jpu rpyhrj;J 
fy;kjk; vd;gJ kiyapDila rj;ijf; Fwpf;Fk;. 
 
ILAGU VIDA MUTTI THYLAM – EXTERNAL MEDICINE 
1. vl;bf;nfhl;il( Strychnos nux -vomica-  Loganiaceae) 
Synonyms:   fhQ;rpuk;> tplKl;b 
Therapeutic Actions: Antiseptic,Carminative, Purgative, Tonic, Stimulant,  
     nghJFzk;:- 
‘iff;fWg;G rd;dp fbtplq;Fl; Litjtyp  
va;f;ftU jhJel;lk; vd;gJk; Nghk; - ikf;fz;zha; 
fl;b fug;ghd; fdkaf;F gpj;jKkpy;  
vl;b kuf; nfhl;il apdhNt” 
2. nts;Ss;sp (Allium sativum – Liliaceae) 
Part used: Bulb  
nghJFzk;:  
              ‘rd;dpNahL thjj; jiyNehT jhs;typ 
kd;dptU ePh;f;Nfhit td;rPjk; - md;dNk 
cs;Ss;sp fz;gha; cis%y NuhfKk; 
nts;Ss;sp jd;dhy; ntUz;L” 
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3. Mapy; gl;il ( Holoptelia Integrifolia- Ulmaecea) 
Synonyms  :  Aayil, Avithal, Poothiyam, Aavil pungu 
Parts used  :  Stem bark 
Therapeutic Actions:  Febrifuge, anti inflammatory, stomachic, laxative 
nghJFzk;: 
  ‘Nkfg; gpbg;gpw;Fk; kpQ;Rkjd; R+iyf;Fk; 
   thFwNt Mah kuj;Njhiyg; - ghfKld; 
   ed;fiuj;J gw;wplNt ehlhJ NehnadNt 
   nghd; kyh;g;G+q; Nfhjha; ! Gfy;      
                                   
4. nts;shl;Lg;ghy! 
 ‘rPjkjp rhuQ; rpNy\;k;kWk; Gz;zhWk;  
 thj rpNy\kKg;Ngh kha;e;J”. 
       nts;shl;Lg; ghypdhy; thjgpj;j njhe;jk; Rthrfhrk;> rPjhjprhuk;> 
fgNjh\k;> tpuzk; > thjj;jpYz;lhfpa tPf;fk; Kjypa Jd;ge; jPUk;. ey;y 
grpAk; cz;lhFk;.  
 
5. ey;nyz;nza; (Sesamum indicum- Pedaliaceae) 
nghJFzk;: 
 ‘Gj;jp eadf; Fsph;r;rp G+hpg;G nka;g;GsfQ; 
 Rj;Jtq; fe;jp jdpapsik - nkj;jTz;lhq;  
 fz;Nzha; nrtpNeha; fghytoy; fhrNeha;  
 Gz;Nzha;Ngh nkd;nza; ahw; Nghw;W” 
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ANNEXURE - II 
GOVT SIDDHA MEDICAL COLLEGE- PALAYAMKOTTAI 
BIO – CHEMICAL ANALYSIS OF AMIRTHA KANTHI KUKKIL VALLATHY 
PREPARATION OF THE EXTRACT: 
5gms of the drug was weighed accurately and placed in a 250ml clean 
beaker.  Then 50ml of distilled water added to it and dissolved well.  Then it was 
boiled well for about 10 minutes. It was cooled and filtered in a 100ml volumetric 
flask and then it is made up to 100ml with distilled water.  This fluid was taken for 
analysis. 
 
Qualitative Analysis 
 
 
S.No. Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract is 
taken in a clean test tube.  To this add 
2 ml of 4% ammonium oxalate 
solution. 
No  white 
precipitate is 
formed. 
Indicates the 
absence of 
calcium. 
2. Test for sulphate: 
2ml of the extract is added to 5% 
barium chloride solution. 
No white 
precipitate is 
formed. 
Indicates the 
Absence of   
sulphate. 
3. Test for chloride 
The extract is treated with silver 
nitrate solution. 
A white 
precipitate is 
formed. 
Indicates the 
presence of 
chloride. 
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4. Test for carbonate 
The substance is treated with 
concentrated HCl. 
No brisk 
effervescence 
is formed. 
Absence of 
carbonate. 
5. Test for Starch 
The extract is added with potassium 
ferro cyanide. 
Blue colour is 
formed 
Indicates the 
presence of  
Starch 
6. Test for iron Ferric 
The extract is treated with 
concentrated glacial acetic acid and 
potassium ferro cyanide. 
No blue 
colour is 
formed. 
Absence of ferric 
iron. 
7. Test for iron Ferrous: 
The extract is treated with 
concentrated nitric acid and 
ammonium thio cyanate. 
Blood red 
colour is 
formed. 
Indicates 
presence of 
ferrous iron. 
8. Test for phosphate 
The extract is treated with ammonium 
molybdate and concentrated nitric 
acid. 
No Yellow 
precipitate is 
formed. 
Indicates the 
Absence of 
phosphate. 
9. Test for albumin 
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
albumin. 
10. Test for Tannic acid 
The extract is treated with ferric 
chloride reagent. 
Blue black 
precipitate  is 
formed 
Indicates the 
Presence of  
Tannic acid 
11. Test for unsaturation 
Potassium permanganate solution is 
added to the extract. 
It gets 
decolorized. 
Indicates the 
presence of 
unsaturated 
compound. 
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12. Test for the reducing sugar 
5ml of benedict’s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 mts and added 8-10 drops of 
the extract and again boil it for 2 mts. 
Colour change 
occurs. 
Indicate the 
presence of 
reducing sugar 
13. Test for amino acid: 
One or two drops of the extract are 
placed on a filter paper and dried it 
well. After drying, 1% ninhydrin is 
sprayed over the same and dried it 
well. 
Violet colour 
is formed. 
Indicates the 
presence of 
Amino acid. 
 
 
14. Test for zinc: 
The extract is treated with potassium 
ferrocyanide 
No white 
precipitated 
Absence of zinc 
 
Result: 
The trial drug AMIRTHA KANTHI KUKKIL VALLATHY contains 
1. Chloride 
2. Starch 
3. Ferrous iron 
4. Tannic acid 
5. Unsaturated compound 
6. Reducing sugar 
7. Amino acid 
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ANNEXURE – III 
GOVT SIDDHA MEDICAL COLLEGE- PALAYAMKOTTAI 
PHARMACOLOGICAL ANALYSIS  
ANALGESIC STUDY OF AMIRTHA KANTHI KUKKIL VALLATHY 
 
Aim: 
 To study the analgesic effect on albino rats by tail flick method. 
Preparation of the test Drug: 
            1 gram of Amirtha kandhi kukkil vallladhy was suspended in 10ml of Hot 
Water as suspending agent. This 1 ml contained 100mg of the test drug. 
 
Procedure: 
                 Nine Male Healthy albino rats (weighing 80-100gms) were used for this 
study. The animals were allowed, free access to food and water until they brought 
for the experiment. The animals which showed the positive response to the 
stimulus (within a given time) were selected for the study. After the selection of 
animals which were responding to stimulus within 2 seconds, they were divided 
into three groups, each group consisting of three rats. 
                 The hot water was maintained at 55°C. The tip of the tail was immersed 
into the water bath and the time was noted when the rat flicked the tail. First group 
was given 1ml of water and kept as control. Second group was administered with 
paracetamol at a dose of 20mg/100gm of body weight. Third group as given the 
dose of 100mg/100gm body weight of the animal .After the drug administration, 
the reaction time of each rat after half an hour and one hour were noted in each 
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group (when a rat fails to flick the tail, it should not be continued beyond 8 
seconds to avoid injury) and the average was calculated. 
The results of control group, standard group and drug treated group were tabulated 
and compared. 
STUDY OF ANALGESIC EFFECT USING THE DRUG AMIRTHA 
KANTHI KUKKIL VALLATHY 
 
Name of the 
Groups 
 
Dose/ 
100 
gram 
body 
weight 
 
 
Initial 
reading 
 
After drug administration 
 
 
Mean 
difference 
 
½ hr 
Average 
 
1 hr 
Average 
 
1 1/2hr 
Average 
 
Control 
(Water) 
 
 
2 ml 
 
2.0 sec 
 
2.0 sec 
 
2.0 sec 
 
2.0 sec 
 
0.0 sec 
 
Standard 
(Paracetamol) 
 
 
20 mg 
 
2.0 sec 
 
2.5 sec 
 
4.5 sec 
 
6.5 sec 
 
4.5 sec 
 
Test drug 
(AKKV) 
 
100 
mg 
 
2.0 sec 
 
2.3 sec 
 
3.5 sec 
 
5.8 sec 
 
3.8 sec 
 
AKKV- Amirtha Kandhi Kukkil Vallathy 
Inference: 
                The trial drug had significant analgesic action. 
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STUDY OF ACUTE ANTI – INFLAMMATORY ACTIVITY IN RATS USING 
THE DRUG AMIRTHA KANTHI KUKKIL VALLATHY 
BY HIND – PAW METHOD 
 
Aim: 
 To demonstrate the acute anti-inflammatory activity of Amirtha kanthi 
kukkil vallathy in albino rats by Hind-paw method. 
 
Procedure: 
  
 Nine healthy albino rats weighing 100-150 gm were taken and divided into 
three groups, each consisting of three rats. 
 
First group was kept as control by giving distilled water orally 2ml/100gm 
body weight. The second group was given ibuprofen at a dose of 20mg /100gm 
body weight. The third group received the test drug at a dose 100mg /100g body 
weight. 
 
Before administration of test drug, the hind-paw volumes of all rats were 
measured. This was done by dipping the hind-paw upto the tibio-tarsal junction 
into a mercury plethysmograph. While dipping the hind-paw, by pulling the 
syringe piston, the level of mercury in the centre small tube was made to coincide 
with red marking and reading was noted from the plethysmograph. 
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Soon after measurement, the drugs were administered orally. One hour 
later, a sub-cutaneous injection of 0.1ml of 1% (W/V) Carrageenan in water was 
made into plantar surface of both hind-paws of each rat. Three hours after 
carrageenan injection, the hind paw volume was measured once again. The 
difference between the initial and final volume was calculated and compared. This 
method is more suitable for studying the anti-inflammatory activity in acute 
inflammation. The values are tabulated. 
 
STUDY OF AMIRTHA KANTHI KUKKIL VALLATHY IN  
ACUTE ANTI – INFLAMMATORY ACTIVITIES 
Group 
Dose volume 
orally 
Initial 
reading 
Final 
reading 
Mean 
difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Control Water 2 ml 0.55 1.45 0.9 100 - 
Standard 
Ibuprofen 
20mg/100gm 
0.55 0.75 0.20 22.2 77.8 
Test drug 
100mg / 
100gm 
0.55 0.85 0.35 38.8 61.2 
 
Result: 
 The drug has significant acute anti-inflammatory action. 
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STUDY OF CHRONIC ANTI-INFLAMMATORY BY COTTON – PELLETS 
GRANULOMA METHOD IN RATS EFFECT USING THE DRUG AMIRTHA 
KANTHI KUKKIL VALLATHY 
Drug: 
 AMIRTHA KANTHI KUKKIL VALLATHY   
Aim: 
 To study the chronic anti-inflammatory activity of the drug in albino rats by 
cotton pellets implantation (granuloma) method. 
Procedures: 
   Cotton pellets each weighing 10mg was prepared and sterilized in an 
autoclave for about one hour under 15 lbs atmosphere pressure.  Nine Albino rats 
weighing between 100-200gm were selected and were divided into 3 groups.  Each 
rat was anaesthetized with ether and cotton pellets were implanted subcutaneously 
in the groin, two in each side. 
 First group was kept as control group giving distilled water of 1ml/100gm 
of body weight. To the second group the standard drug Ibuprofen in a dose of 
20mg/100gm body weight was given.  The third group of animals was given test 
drug Amirtha Kandhi Kukkil Vallathy in a dose of 100mg/100gm of body weight 
 On the eighth day the rats were sacrificed and the pellets were removed and 
weighed.  Then they were put in an incubator at 60ºC-80ºC and then weighed. 
The concordant weight was noted for all groups and compared. 
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THE EFFECT OF AMIRTHA KANTHI KUKKIL VALLATHY IN 
CHRONIC ANTI – INFLAMMATORY STUDY 
Group 
Dose given 
orally 
Pellet 
Weight 
Pellet 
Weight of 
the 
Granuloma 
of drugs 
Percentage 
inflammation 
Percentage 
inhibition 
Control Water 2 ml 10 mg 250 mg 100 - 
Standard 
Ibuprofen 
20mg/100gm 
body weight 
10mg 55mg 22 78 
Test 
drug 
100mg/100gm 
body weight 
10 mg 120 mg 48 52 
 
Inference: 
 The drug AMIRTHA KANTHI KUKKIL VALLATHY shows 
Moderate chronic anti – inflammatory action. 
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ACUTE ANTI - INFLAMMATORY STUDY ON ILAGU VIDA MUTTI 
THYLAM (EXTERNAL USE)  
BY HIND-PAW METHOD IN ALBINO RATS 
Aim: 
 To study the acute anti-inflammatory activity of the test drug ILAGU 
VIDA MUTTI THYLAM  
Preparation of the test drug: 
The Ilagu vida mutti thylam was prepared as per the preparation 
given in siddha vaithiya thirattu 
Procedure: 
Nine healthy albino rats weighing 100-150gm were taken and divided into 
three groups, each consisting of 3 rats. 
First group was kept as control by giving distilled water of 2ml/100gm of 
body weight. The second group was kept as test group. The third group was given 
the standard drug. 
Before application of the test drug the Hind-paw volume of all the rats 
were measured. This was done by dipping the Hind-paw up to the tibio-
femoral junction into a mercury plethysmograph. While dipping the Hind-paw, 
by pulling the syringe piston, the level of mercury in the centre small tube was 
made to coincide with red marking and reading was noted from the 
plethysmograph. 
One hour later, a sub-cutaneous injection of 0.1ml of l %( w/r)  
Carrageenan water made into plantar surface of both Hind-paw of each rat. To 
the second (last) group Ilagu vida mutti thylam was topically applied for three 
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times over the inflammed surface in a thin layer for every 15mts for an hour. 
To the contol group no drug was applied over the inflammed surface. To the 
standard group the standard drug Ibuprofen in a dose of 20mg/100gm body weight 
was given. 
Three hour after injection the Hind-paw volume was measured once again.  
The difference between the initial and final volume would show the amount of 
inflammation.  Taking the volume in the control group as 100% of inflammation, 
anti – inflammatory effect of the test group is calculated. 
EFFECT OF ILAGU VIDA MUTTI THYLAM 
 
Group Drugs 
Dose 
100 
gm of 
body 
weight 
Initial 
value 
Final 
value 
Difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Control Water 2ml 0.55 1.45 0.9 100 - 
Standard Ibuprofen 20mg 0.55 0.75 0.20 22.2 77.8 
Test 
drug 
IVMT Ext 0.70 1.1 0.4 44.4 55.6 
 
IVMT- ILAGU VIDA MUTTI THYLAM 
Inference:  The test drug has MODERATE anti-inflammatory action externally. 
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ANNEXURE – IV 
ASSESSMENT FORMS 
 
FORM I - SCREENING FORM 
FORM II - CONSENT FORM 
FORM III - CASE  PROFORMA 
FORM IV - LABORATORY INVESTIGATIONS 
FORM V - CLINICAL ASSESSMENT 
FORM VI -  PATIENT WITHDRAWAL FORM 
FORM VII - DRUG COMPLIANCE FORM 
 
 
  
        
       
        
       
 
 
 
 
164 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF AMIRTHA KANDHI KUKKIL VALLATHY & 
ILAGU VIDA MUTTI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
FORM I –SCREENING FORM 
 
 1. OP/ IP No:                                                  2. BED No:                    
 3. Sl. No:            4.   NAME:  
5. AGE:                                         6. GENDER:  
 7.   OCCUPATION:                                       8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                          10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
 
I. INCLUSION CRITERIA: 
1. Sex:  Both Male and Female. 
2. Pain and swelling present in knee joints. 
3. Crepitations present in knee joints.   
4. Early morning stiffness. 
5.  Tenderness 
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II. EXCLUSION CRITERIA: 
1. Diabetes Mellitus 
2. Hypertension  
3. Cardiac diseases 
4. Pregnancy and Lactation 
5. Patients with any other serious illness 
6. Peptic ulcer 
7. Severe trauma 
8. Any other systemic diseases 
 
 III. WITHDRAWAL CRITERIA: 
               1. Development of any adverse reaction (ADR 
                2. Occurrence of any other systemic illness. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF AMIRTHA KANDHI KUKKIL VALLATHY & ILAGU 
VIDA MUTTI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
Form: II CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
Signature………………….          Date……                                                                                                                                                                                                                
Name…………………… 
 
CONSENT BY PATIENT 
 
I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up 
including the laboratory investigations to be performed to monitor and safeguard 
my body functions.  
I am aware of my right to opt out of the trial at any time during the course 
of the trial without having to give the reasons for doing so. 
I, exercising my free power of choice, hereby give my consent to be 
included as a subject in the clinical trial of ‘Amirtha kandhi kukkil vallathy 
(Internal drug)’ and ‘Ilagu vida mutti thylam (External drug)’ for the treatment of 
‘Azhal keel vaayu’ (osteoarthritis). 
 
Signature………………….          Date……………….                                                                                                                                                                                                                
Name………………… 
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murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid>ghisaq;Nfhl;il 
gl;lNkw;gbg;G rpwg;GkUj;Jtj;Jiw 
‘mkpu;j fe;jp Ff;fpy; ty;yhjp ” kw;Wk; ’,yF tpl Kl;b ijyk ;” ,tw;wpd; 
gupfupg;Gj;jpwidf; fz;lwpAk; kUj;Jt Ma;T 
Xg;Gjy; gbtk; 
 
 
Ma;thsuhy; rhd;wspf;fg;gl;lJ 
 
 ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F 
GupAk; tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp:                                 ifnahg;gk;: 
,lk;:                                   ngau;: 
 
Nehahspapd; xg;Gjy; 
                   
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik 
kw;Wk; kUj;Jt topKiwiag; gw;wpAk; njhlu;e;J vdJ cly; ,af;fj;ij 
fz;fhzp;f;fTk>; mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l 
gupNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; 
tpsf;fpf; $wg;gl;lJ. 
 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; 
vg;nghOJ Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; 
nfhs;Sk; cupikia njupe;jpUf;fpd;Nwd;. 
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 ehd; vd;Dila Rje;jpukhfj; Nju;T nra;Ak; cupikiaf; nfhz;L 
moy; fPy; thA vd;Dk; Neha;f;fhd ‘mkpu;j fe;jp Ff;fpy; ty;yhjp ” kw;Wk; 
‘ ,yF tpl Kl;b ijyk; “ Mfpatw;wpd;  gupfupg;Gj; jpwidf; fz;lwpAk; 
kUj;Jt Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;. 
 
Njjp:                                     ifnahg;gk;: 
,lk;:                                  ngau;: 
Njjp:                          rhl;rpf;fhuh; ifnahg;gk;: 
,lk;:                                        ngau; 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF AMIRTHA KANDHI KUKKIL VALLATHY 
& ILAGU VIDA MUTTI THYLAM FOR AZHAL KEEL VAAYU 
(OSTEOARTHRITIS) 
FORM III – CASE PROFORMA 
1. OP/ IP No:                                           2. BED No:                            3. Sl. No:  
 4.   NAME:                                              5. AGE:                                  6. GENDER:  
 7.   OCCUPATION:                                    8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                        10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
---------------------------------------------------------------------------------------------------- 
12. COMPLAINTS & DURATION:    
13. HISTORY OF PRESENT ILLNESS:  
14. PAST HISTORY:  
15. FAMILY HISTORY: 
Lecturer                         HOD 
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16. MENSTRUAL HISTORY (If applicable):  
17. HABITS:                                  Yes               No                                                                                                                                                                                             
1. Smoker     
2. Alcoholic 
3. Betel nut chewer 
4. Non-Veg /Vegetarian      
5. Drug addiction                                 
18. GENERAL EXAMINATION: 
1. Body weight [Kg]         :                      
2. Height [cm]                        :                      
3. Body Temperature [oF]       :   
4. Blood Pressure (mmHg) :      
5. Pulse Rate /min.  : 
6. Heart Rate /min.   : 
7. Respiratory Rate /min.  :   
                                                        Yes            No   
8. Pallor : 
9. Jaundice :   
10. Clubbing : 
11. Cyanosis : 
12. Pedal Oedema : 
13. Lymphadenopathy    :                                        
14. Jugular venous pulsation:  
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19. CLINICAL EXAMINATION OF KNEE JOINT: 
I. INSPECTION                                Present      Absent 
        1. Swelling     …………………………… 
        2. Muscle wasting     …………………………… 
        3. Deformity      …………………………… 
II. PALPATION: Present            Absent 
    1. Tenderness           ………………………….. 
    2. Swelling          ……………………………  
    3. Crepitations           …………………………… 
  4. Warmth                   ……………………………… 
III. MOVEMENTS:  
1. Restriction of Movements in the Knee joint:  Full           Partial              No 
2. KNEE:  PAIN  MUSCULAR SPASM ROM 
                                             Yes   No        Yes      No           Normal        Reduced 
    i. Flexion       
         ii. Extension 
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3. NEUROLOGICAL EXAMINATION: 
   i. Sensation  Normal                     Abnormal                  
   ii. Tone                         Normal                  Abnormal                   
  iii. Power                      Normal                    Abnormal                  
  iv.Muscle wasting  Present                   Absent                      
4. REFLEXES:                      Normal    Exaggerated  
        i. Knee jerk 
        ii. Ankle jerk 
20. CLINICAL ASSESSMENT: 
I. PAIN: 
A. Pain in the knee joints:       No            Mild                  Moderate         Severe  
       
          i. Onset         Sudden                       Gradual              
         ii. Nature:         Local                           Diffuse        Others 
B. Nature of pain   Shooting                       Burning       Others 
   
   YES                NO 
C. Pain during movements          
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II. Morning stiffness 
III.Tenderness                                                                                                                                                                       
III. Swelling             
IV. Restricted joint movements                                                                                              
21. EXAMINATION OF OTHER SYSTEMS: 
   Normal       Abnormal 
1.  CVS  
2.  RS    
3.  CNS 
4. ABDOMEN   
            5.  GENITO-URINARY                                         
 
SIDDHA ASPECTS 
1. NILAM: 
       1. Kurinji            2. Mullai          3. Marutham       4. Neithal           5. Paalai 
2 . KAALAM: 
         1. Kaar Kaalam    2. Koothir Kaalam          3. Munpani Kaalam      
         4. Pinpani Kaalam          5. Ilavenir Kaalam 6. Muduvenir Kaalam 
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3. YAAKKAI: 
 1. Vatham          2. Pitham      3. Kabam     
4. Vathapitham        5. Pithavatham    6. Kabavatham       
7. Vathakabam        8. Pithakabam              9. Kabapitham    
4. GUNAM: 
 1. Sathuvam  2. Rasatham             3. Thamasam 
5. IYMPORIGAL:    Normal   Affected   
1.  Mei                                   ..………………………………….. 
2. Vaai                                    ……………………………………... 
3.  Kan                                   ……………………………………… 
4. Mookku                             ……………………………………… 
5.  Sevi                                   …………………………………………… 
6. KANMENDHIRIUM / KANMAVIDAYAM: 
   Normal   Affected    
1. Kai                                            …………………………………………... 
2. Kaal                                          …………………………………………... 
3. Vaai                                           ………………………………………….. 
4. Eruvaai                                      …………………………………………..  
5. Karuvaai                                    ………………………………………….. 
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7. UYIR THATHUKKAL: 
I. VATHAM:     Normal    Affected 
1. Piraanan                                      ………………………………………… 
2.  Abaanan                                    ………………………………………….    
3. Viyaanan                                 ………………………………………….   
4.  Uthaanan                                    ……………………………………    
5. Samaanan                                    ……………………………………                             
6. Naagan                                      ……………………………………….    
7. Koorman                                  …………………………………………... 
8. Kirukaran                                   …………………………………………...         
9. Devathathan                               …………………………………………     
10. Dhananjeyan                            …………………………………………  
II. PITHAM :             Normal    Affected 
1. Analam                                     ……………………………………….         
2. Ranjagam                                 ………………………………………….   
3. Saathagam                                  ………………………………………..     
4. Aalosagam                                 ……………………………………….           
5. Prasagam                                   …………………………………….. 
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III. KABAM:     Normal    Affected 
1. Avalambagam                       …………………………………………… 
2. Kilethagam                             …………………………………………… 
3. Pothagam                                 …………………………………………… 
4. Tharpagam                               ……………………………….…………... 
5. Santhigam                                …………………………………………… 
8. UDAL THATHUKKAL: Normal   Affected 
1.  Saaram                                                     ……………………………… 
2. Senneer                                                ……………………………… 
3.  Oon                                                                 ……………………………. 
4.  Kozhuppu                                                       ……………………………. 
5. Enbu                                                                ……………………………. 
6. Moolai                                                             …………………………… 
7. Sukkilam/Suronitham                                   ……………………………. 
9. ENVAGAI THERVUGAL: 
 1 . Naadi    ……………………………………………………. 
                              Normal    Affected 
2. Sparisam                                           ………………………….. 
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3. Naa                                                       …………………………… 
4. Niram                                            …………………………….. 
5. Mozhi                                                      …………………………….. 
6. Vizhi                                                        …………………………….. 
7. Malam 
      a. Niram                                  …………………………….. 
      b. Nurai                                   …………………………….. 
      c. Kirumi                    .…………………………….. 
      d. Thanmai:    i. Irugal                 ii. Ilagal                           
  8. Moothiram: 
I. NEERKKURI   Normal    Affected 
     a. Niram                             …………………………….. 
     b . Manam                      …              …………………………….. 
     c. Edai                       …………………………….. 
     d. Nurai                    …………………………….. 
     e. Enjal                                             …………………………….. 
II. NEIKKURI: ………………………………………. 
          Vatha Neer             Pitha Neer            Kaba Neer 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF AMIRTHA KANDHI KUKKIL VALLATHY & 
ILAGU VIDA MUTTI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
Form IV - LABORATORY INVESTIGATIONS 
1. OP/ IP No:                                                 2. BED No:                           3. Sl. No:  
 4.   NAME:                                                      5. AGE:                                 6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ENROLMENT:                        10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
Date: 
I. BLOOD: 
1. TC :    (Cells/Cumm)          
2. DC (%):   N                L                        M             E                      
3. ESR (mm) :    ½ hr                           1 hr 
4. Hb:  
5. Total RBC:                
Lecturer                         HOD 
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6. Blood Sugar:   a) Fasting                       b) Post prandial                        
7. Kidney function tests: 
              Blood urea:   Serum creatinine: 
8. Lipid profile: 
              HDL:    LDL:              VLDL:   
              Total Cholesterol :  TGL: 
9. Liver Function tests: 
              SGOT:   SGPT:  Alk. Phosphatase: 
               Albumin:   Globulin:  Total Protein: 
               Serum Bilirubin:         Total  Direct  Indirect : 
      II. URINE: 
1. Albumin :                                                    
2. Sugar :                                                           
3. Epithelial cells   :                 
4. Pus cells             :                 
5. Red blood cells  :                 
6. Casts/Crystals    : 
III. MOTION:    
1. Ova    : 
2. Cyst    : 
3. Occult blood   : 
4. Pus cells   : 
IV. X-RAY: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF AMIRTHA KANDHI KUKKIL VALLATHY & 
ILAGU VIDA MUTTI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
FORM V – CLINICAL ASSESSMENT 
1.  OP/ IP No:                                                 2. BED No:                           3. Sl. No:  
 4.   NAME:                                                      5. AGE:                                 6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                          10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
CLINICAL EXAMINATION OF KNEE JOINT: 
I. INSPECTION:                    Present      Absent 
        1. Swelling     …………………………… 
        2. Muscle wasting     …………………………… 
        3. Deformity      …………………………… 
II. PALPATION: Present            Absent 
    1. Tenderness            ……………………… 
Lecturer                         HOD 
181 
 
    2. Swelling              …………………………  
    3. Crepitations     ……………………………… 
  4. Warmth               ……………………………… 
III. MOVEMENTS:  
1. Restriction of Movements in the Knee joint:  Full         Partial              No 
2. KNEE:  PAIN MUSCULAR SPASM ROM 
                                                 Yes   No        Yes   No                Normal    Reduced 
            i. Flexion  
            ii. Extension 
3. NEUROLOGICAL EXAMINATION: 
             i. Sensation: Normal                             Abnormal                  …………... 
             ii. Tone         Normal                        Abnormal                  ………….. 
             iii. Power      Normal                              Abnormal                 ..………… 
             iv. Muscle wasting:  Present              Absent            …………. 
4. REFLEXES:               Normal   Exaggerated  
        i. Knee jerk 
        ii. Ankle jerk 
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20. CLINICAL ASSESSMENT: 
I. PAIN: 
A. Pain in the knee joints:      No                  Mild       Moderate          Severe  
         i. Onset              Sudden                          Gradual              
         ii. Nature:           Local                             Diffuse          Others 
B. Nature of pain       Shooting                         Burning          Others     
       Yes                  No 
C. Pain during movements     
II. Morning stiffness 
III.Tenderness                                                                                                                                                                     
III. Swelling             
IV. Restricted joint movements                                                                                           
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF AMIRTHA KANDHI KUKKIL VALLATHY 
& ILAGU VIDA MUTTI THYLAM FOR AZHAL KEEL VAAYU 
(OSTEOARTHRITIS) 
FORM - VI PATIENT WITHDRAWAL FORM 
1.  OP / IP No       …………    2. S.No. ………………     3.Date: …………… 
4.  Name    ………………….. 5. Age ……………           6. Gender ………… 
7.  Postal address: 
---------------------------------------------------------------------------------------------------- 
Complaints and Duration: 
 
 
Irregular treatment: 
 
 
Other causes: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF AMIRTHA KANDHI KUKKIL VALLATHY & 
ILAGU VIDA MUTTI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
FORM VII - DRUG COMPLIANCE FORM 
Name of the Drug: AMIRTHA KANDHI KUKKIL VALLATHY 
Drugs issued: ……………(mgs/Grams) 
Drugs returned:  ……………(mgs/Grams) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                     Signature of the HOD 
S.NO DATE 
DRUG TAKEN TIME 
MORNING/TIME AFTERNOON/TIME NIGHT/TIME 
Day 1     
Day 2     
Day 3     
Day 4     
..     
..     
Up to day 
48 
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